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ABSTRACT 
Alice Stamatakis: Delineating midbrain circuits underlying motivated behaviors 
 (Under the direction of Garret Stuber) 
 
Lateral habenula (LHb) neurons convey aversive and negative reward 
conditions through potent indirect inhibition of ventral tegmental area (VTA) 
dopaminergic neurons.  Although the LHb and VTA reciprocally project to each other, 
the electrophysiological properties and the behavioral consequences associated with 
selective manipulations of this circuit are unknown.  We found that exposure to 
aversive stimuli in mice increased LHb excitatory drive onto RMTg neurons.  
Furthermore, optogenetic activation of this pathway promoted active, passive and 
conditioned behavioral avoidance.  Thus, activity of LHb efferents to the midbrain is 
aversive, but can also serve to negatively reinforce behavioral responding.  Aspects 
of this behavioral phenotype were recapitulated by optogenetically activating lateral 
hypothalamic (LH) glutamatergic inputs to the LHb, suggesting that the LH may be an 
important upstream contributor to aversive signaling of LHb neurons.  Optogenetic 
activation of VTA dopaminergic inputs to the LHb resulted in no detectable dopamine 
release in LHb brain slices.  Instead, stimulation produced GABA-mediated inhibitory 
synaptic transmission, which suppressed the firing of postsynaptic LHb neurons in 
brain slices and increased the spontaneous firing rate of VTA dopaminergic neurons 
in vivo.  Furthermore, in vivo activation of this pathway produced reward-related 
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phenotypes that were dependent on intra-LHb GABAA receptor signaling.  These 
results suggest that noncanonical inhibitory signaling by these hybrid dopaminergic-
GABAergic neurons acts to suppress LHb output under rewarding conditions.  
Collectively, these data demonstrate that the LHb and midbrain interact in a 
reciprocal manner and implicate the VTA’s projection to the LHb as a key node in the 
classical midbrain reward circuit.  
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CHAPTER 1. GENERAL INTRODUCTION1 
 
HISTORY AND FUNCTION OF DOPAMINE 
Animals are constantly faced with the necessity to seek out rewards, such as 
food and mates, while at the same time avoid dangerous and harmful situations.  
Therefore, motivated behaviors directed towards reward seeking and avoidance 
have evolved to promote survival across species (O’Connell and Hofmann, 2011).  
The brain reward system has been identified as an essential regulator for processing 
appetitive and aversive stimuli as well as generating appropriate motivated 
behaviors directed towards such stimuli.  Specifically, dopaminergic neurons arising 
from the ventral tegmental area (VTA) and substantia nigra are integral for diverse 
neural functions including sensorimotor functions, motor control, motivation, reward 
seeking, salience detection, and novelty (Bromberg-Martin et al., 2010a; Schultz, 
2007; Wise, 2004).   
 The notion that reward seeking is driven by neurological functions was first 
demonstrated by Olds and Milner in a seminal 1954 study (OLDS and MILNER, 
1954).  Olds and Milner demonstrated that rats would press a lever for electrical 
stimulation of “pleasure centers” in the brain.  This study fostered numerous 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  
1Sections from this chapter previously appeared in a book chapter published in the 
book Addiction. The original citation is as follows.  Stamatakis, A.M., and Stuber, 
G.D. (2012) Optogenetic strategies to dissect the neural circuits that underlie reward 
and addiction.  Cold Spring Harb Perspect med. 11, a011924.  	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subsequent investigations to determine the exact neurotransmitter and neural 
circuits that underlie this phenomenon.  Successive electrophysiological, 
pharmacological, and behavioral studies identified dopamine as the neurotransmitter 
that was critical for reward seeking and motivated behaviors (Wise, 2008).  
While it is clear that dopamine signaling contributes to reward, a debate has 
ensued over the precise role of dopamine to reward.  Two prominent theories have 
emerged: reward prediction error and incentive salience.  Studies supporting the role 
for dopamine in reward prediction have found that dopamine computes the 
difference between an expected outcome and the actual outcome, and thus can act 
as a teaching signal (Cohen et al., 2012; Schultz et al., 1997; Wise, 2005).  Incentive 
salience argues that dopamine functions to promote reward seeking by attributing an 
incentive salience to reward-predictive cues (Berridge, 2007).  However, these two 
hypotheses should not be viewed as mutually exclusive, and it is likely that 
dopaminergic neurons have multiple roles in reward behavior, and can act as both a 
teaching signal and to signal incentive salience.  
In addition to reward processing, dopaminergic neurons have also been 
identified as a key neural substrate in processing aversion.  VTA neurons respond to 
aversive stimuli, and the cues that predict these stimuli, in a complex and diverse 
pattern (Bromberg-Martin et al., 2010a).  It is likely that much of this diversity and 
complexity arises from the heterogeneity of VTA neurons, as well as the connectivity 
of the VTA with a multitude of different inputs and outputs. Therefore, discerning the 
precise role of dopamine in reward and aversion requires intense investigation of the 
	   3	  
function of select subpopulations of dopaminergic neurons, and the precise control 
and manipulation of specific VTA afferents and efferents.  
 
COMPOSITION AND HETEROGENEITY OF THE VTA 
Anatomy and Cellular Composition of the VTA 
The VTA is a midbrain structure that houses the A10 group of dopaminergic 
neurons (Dahlstroem and Fuxe, 1964).  Cytoarchitectonic identification of the VTA is 
difficult, due to the lack of clear borders, and thus the VTA is often identified by it’s 
location to neighboring structures (Fields et al., 2007).  The VTA is located posterior 
to the hypothalamus, anterior to the brainstem reticular formation, medial to the 
substantia nigra, and ventral to the red nucleus.  
The VTA is comprised of a heterogeneous population of neuronal subtypes 
containing approximately 65% dopaminergic neurons, 30% GABAergic neurons, and 
5% glutamatergic neurons (Van Bockstaele and Pickel, 1995; Carr and Sesack, 
2000a; Dobi et al., 2010; Margolis et al., 2006).  However, a more detailed analysis 
of the composition of VTA neurons reveals that it is more complicated.  Recent 
studies have demonstrated that midbrain VTA dopaminergic neurons are capable of 
co-transmitting both GABA and glutamate (Stuber et al., 2010; Tecuapetla et al., 
2010; Tritsch et al., 2012).  Consequently, it is not completely accurate to describe 
the VTA as a population of discrete dopaminergic, glutamatergic, and GABAergic 
neurons.  It should be noted, though, that it is unclear what percentage of VTA 
neurons are co-releasing multiple classical neurotransmitters.  The cellular 
composition of the VTA also varies along the anterior-posterior and medial-lateral 
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axis.  VTA non-dopaminergic glutamatergic neurons are located more densely in the 
medial and anterior portions of the VTA (Yamaguchi et al., 2007).  While GABAergic 
neurons are located throughout the VTA, more posterior regions of the VTA tend to 
have a higher percentage of GABAergic neurons than the anterior regions (Jhou et 
al., 2009a; Kaufling et al., 2009).  
 
Heterogeneity of VTA dopaminergic neurons 
A number of recent studies have demonstrated that VTA dopaminergic 
neurons themselves are heterogeneous in terms of their electrophysiological 
properties, their molecular profile, anatomical location, and projection field.  In brain 
slices, dopaminergic neurons have traditionally been identified based on the 
presence of a hyperpolarization-activated inward rectifying current (Ih)(Margolis et 
al., 2006; Mercuri et al., 1995).  Recently, however, studies have demonstrated that 
not all dopaminergic neurons have Ih currents (Lammel et al., 2008; Margolis et al., 
2006).  While basolateral amygdala (BLA)- and nucleus accumbens (NAc)-projecting 
VTA dopaminergic neurons have an Ih current, medial prefrontal cortex (mPFC)-
projecting VTA dopaminergic neurons do not (Ford et al., 2006; Lammel et al., 
2008).  A pharmacological marker of a subset of dopaminergic neurons in vitro is 
inhibition in response to a D2 dopamine autoreceptor activation (Beckstead et al., 
2004).  While NAc- and BLA-projecting VTA dopaminergic neurons have functional 
D2 autoreceptors, mPFC-projecting VTA dopaminergic neurons do not show 
inhibitions to D2 autoreceptor activation, and thus do not appear to have functional 
D2 autoreceptors on the soma (Lammel et al., 2008).  Consequently, previous 
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studies examining dopaminergic neurons using these electrophysiological criteria in 
brain slices may have excluded mPFC-projecting dopaminergic neurons. 
Dopaminergic neurons, and likely VTA neurons in general, are 
heterogeneous with respect to their connectivity.  In general, VTA dopaminergic 
neurons do not collateralize to other regions of the brain, and thus separate 
populations of dopamine neurons project to nonoverlapping target structures (Ford 
et al., 2006; Lammel et al., 2008; Swanson, 1982). Therefore, VTA dopaminergic 
neurons can be categorized based on their projection target.  It is also likely, 
although less clear, that dopaminergic neurons receive unique inputs.  Supporting 
this idea, the lateral habenula (LHb) projects predominantly onto mPFC-projecting 
dopaminergic neurons, while the laterodorsal tegmentum (LDT) synapses primarily 
onto NAc-projecting dopaminergic neurons (Lammel et al., 2012).  Dopaminergic 
neurons are also anatomically segregated.  BLA-projecting VTA dopaminergic 
neurons are located in the anterior-lateral portions of the VTA (Ford et al., 2006), 
NAc-projecting VTA dopaminergic neurons are located in the posterior-medial VTA 
(Ford et al., 2006; Lammel et al., 2008), and mPFC-projecting VTA dopaminergic 
neurons are located in the anterior-medial regions of the VTA (Nair-Roberts et al., 
2008; Yamaguchi et al., 2007). 
Finally, depending on projection target, VTA dopaminergic neurons have 
heterogeneous molecular profiles.  BLA-, mPFC-, NAc core-, and NAc medial shell-
projecting VTA dopaminergic neurons have small dopamine transporter (DAT)/ 
tyrosine hydroxylase (TH) mRNA expression ratios compared to VTA dopaminergic 
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neurons projecting to the lateral shell of the NAc, and SN neurons projecting to the 
dorsal striatum (Lammel et al., 2008).  
 
VTA CIRCUITRY  
Interconnectivity within the VTA 
Along with receiving a multitude of inputs from across the brain, which is 
discussed in detail below, the VTA is also locally controlled by GABAergic, 
glutamatergic, and dopaminergic neurons.  VTA GABAergic neurons locally inhibit 
VTA dopaminergic neurons, and activation of VTA GABAergic neurons decreases 
electrically-evoked dopamine release in the NAc (van Zessen et al., 2012), 
suggesting that VTA GABAergic neurons synapse onto NAc-projecting VTA 
dopaminergic neurons.  However, it remains unclear whether VTA GABAergic 
neurons inhibit other subpopulations of VTA dopaminergic neurons.  In vivo 
electrophysiological recordings from optically-tagged VTA GABAergic neurons 
demonstrate that these neurons show increases in firing when a reward is expected, 
and in response to aversive stimuli (Cohen et al., 2012; Tan et al., 2012).  
Additionally, optogenetic activation of VTA GABAergic neurons is aversive and 
disrupts reward consumption (Tan et al., 2012; van Zessen et al., 2012).  Combined, 
these studies implicate a significant role for VTA GABAergic signaling in reward and 
aversion.  However, it is unclear if these effects are due to local inhibition of VTA 
dopaminergic neurons, or due to inhibition of a downstream target of VTA 
GABAergic neurons.  It is also currently unknown whether local VTA GABAergic 
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neurons collateralize and project to other brain structures, or if there is a population 
of GABAergic interneurons separate from GABAergic projection neurons.   
The rostromedial tegmental nucleus (RMTg) is a GABAergic structure located 
immediately posterior of the VTA.  Also called the tail end of the VTA, the RMTg is 
considered a GABAergic posterior extension of the VTA (Kaufling et al., 2009).  
GABAergic RMTg neurons also directly inhibit VTA dopaminergic neurons (Matsui 
and Williams, 2011).  Similar to VTA GABAergic neurons, RMTg neurons also show 
increases in firing in response to noxious stimuli (Hong et al., 2011; Jhou et al., 
2009b).  While VTA GABAergic neurons and RMTg neurons show similar responses 
to aversive stimuli, the two structures appear to be distinct in terms of connectivity.  
The VTA sends GABAergic projections to the forebrain, while the RMTg lacks these 
projections (Van Bockstaele and Pickel, 1995; Carr and Sesack, 2000a; Jhou et al., 
2009a; Kaufling et al., 2010; Taylor et al., 2014).  Additionally, while the VTA and 
RMTg both receive LHb afferents, the LHb projection to the RMTg is notably more 
robust (Balcita-Pedicino et al., 2011). 
Dopaminergic neurons also release dopamine locally via somatodendritic 
release (Björklund and Lindvall, 1975; Geffen et al., 1976).  Dopamine receptor D2 
autoreceptors are expressed on the soma and dendrites of midbrain dopaminergic 
neurons.  These D2 receptors are coupled to G protein-coupled potassium channels 
(GIRK2), and thus activation of D2 receptors hyperpolarizes dopaminergic neurons 
(Beckstead et al., 2004).  Dopaminergic neurons also release dopamine 
spontaneously within the VTA, resulting in a G protein-couple receptor-mediated 
inhibitory postsynaptic currents (Gantz et al., 2013; Jaffe et al., 1998).  
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Glutamatergic neurons in the VTA also release glutamate locally to control the 
activity of VTA dopaminergic and non-dopaminergic neurons (Dobi et al., 2010), 
although the function of this local glutamatergic release is uncertain.  
 
Optogenetic activation of dopaminergic neurons 
 It has been clear for nearly 40 years that dopamine underlies aspects of 
reward and motivation (Wise, 2008).  However, due to technical restraints, the exact 
causal relationship between dopamine and reward was difficult to ascertain.  Within 
the last six years a number of studies have utilized optogenetics to selectively excite, 
inhibit, and record from dopaminergic neurons to help establish a causal relationship 
between dopamine and behavior.  
Optogenetic activation of VTA dopaminergic neurons has confirmed that 
phasic activation of dopaminergic neurons is sufficient to produce behavioral 
conditioning and promote reward (Tsai et al., 2009).  In addition, activation of 
dopaminergic neurons is also reinforcing, as mice and rats will self-administer optical 
activation of VTA dopaminergic neurons, and projections to the NAc, demonstrating 
that reinforcement and reward can arise solely within the dopaminergic system (Kim 
et al., 2012; Steinberg et al., 2014; Witten et al., 2011).  Finally, phasic activation of 
dopaminergic neurons to mimic a reward prediction error is sufficient to cause long-
lasting reward-seeking behavior (Steinberg et al., 2013).  Collectively, these data 
demonstrate a causal role for dopamine in reinforcement learning.   
Dopamine has also been thought to contribute to the pathophysiology of 
psychiatric disorders such as depression.  Importantly, using optogenetics, two 
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recent studies have begun to address this hypothesis and found that dopaminergic 
neurons mediate aspects of depression (Chaudhury et al., 2013; Tye et al., 2013).  
Interestingly, Tye et al. found that activation of VTA dopaminergic neurons could 
alleviate symptoms of depression, while Chaudhury et al. demonstrated that 
activation of dopaminergic neurons promoted aspects of depression.  These 
paradoxical findings could be the result of the different techniques the authors used 
to produce the depressive-like symptoms.  While Tye et al. used a milder form of 
stress to induce depressive-like symptoms, Chaudhury et al. used a more intense 
chronic social-defeat stressor.  Nonetheless, these studies provide a direct link 
between dopaminergic firing and depression and underscore the complexity of 
neuropsychiatric diseases and the circuitry underlying these diseases.  
 
Inputs to the VTA 
VTA dopaminergic neurons are phasically excited by rewards, and the cues 
that predict these rewards, and are phasically inhibited by the omission of rewards 
(Cohen et al., 2012; Schultz et al., 1997).   And, as discussed above, dopaminergic 
neurons show heterogeneous responses to aversive events, and the cues that 
predict these aversive events.  The VTA receives diverse afferents from throughout 
the brain, but the precise brain areas that provide input to VTA neurons and 
communicate reward- and aversive-related information remains relatively unknown.  
Recent studies using optogenetics have begun to provide insight into which inputs 
are controlling aspects of motivated behaviors.  Using an elegant and novel 
monosynaptic tracing study Watabe-Uchida et al. identified VTA afferents throughout 
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the brain (Watabe-Uchida et al., 2012).  Importantly, this study was able to identify 
monosynaptic inputs directly to VTA dopaminergic neurons.  This study identified 
well-known inputs to VTA dopaminergic neurons, such as the bed nucleus of the 
stria terminalis (BSNT), lateral hypothalamus (LH), LHb, dorsal raphe (DRN), and 
laterodorsal tegmental nucleus (LDT).  However, the study also identified novel 
dopaminergic afferents, such as the NAc and paraventricular hypothalamus (PVN).  
 
Lateral hypothalamus 
A variety of limbic regions project to the VTA and affect various components 
of motivated behaviors.  One of the most well studied limbic input to the VTA arises 
from the LH.  The LH is a heterogeneous structure that regulates aspects of 
homeostasis and is critical for a variety of motivated behaviors (Sternson, 2013).  
Therefore, the connection between the LH and the VTA may be necessary for 
guiding motivated behavior directed towards maintaining homeostasis.  Anatomical 
and electrophysiological evidence suggests that the LH sends glutamatergic, 
GABAergic, and peptidergic projections to the VTA, where they make connections 
onto both dopaminergic and non-dopaminergic VTA neurons (Edinger et al., 1977; 
Geisler et al., 2007; Hernandez and Hoebel, 1988; Korotkova et al., 2003; Maeda 
and Mogenson, 1981).  Peptidergic projections from the LH include orexin, 
neurotensin, dynorphin, melanin-concentrating hormone (MCH) and cocaine- and 
amphetamine-regulated transcript (CART) (Bittencourt et al., 1992; Dallvechia-
Adams et al., 2002; Fadel and Deutch, 2002; Woulfe and Beaudet, 1992).  Mice will 
self-administer optical stimulation of LH fibers in the VTA and the rewarding effects 
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of activation of the LH-to-VTA pathway is attenuated by blockade of endogenous 
neurotensin and NDMA receptor signaling (Kempadoo et al., 2013).  However, given 
the complexity of the projections from the LH to the VTA, the precise integration and 
segregation of LH afferents, and their role in motivated behavior and homeostatic 
regulation will require further investigation.    
 
Striatum 
Although the VTA-to-NAc circuit has received much attention for it’s role in 
motivation and reward seeking (discussed below), the NAc also sends a reciprocal 
projection back to the VTA (Heimer et al., 1991; Kalivas et al., 1993; Lu et al., 1998; 
Nauta et al., 1978; Tripathi et al., 2010; Usuda et al., 1998). Dopamine receptor D1-
expressing GABAergic medium spiny neurons (MSNs) in the NAc synapse onto 
GABAergic neurons in the VTA (Bocklisch et al., 2013; Xia et al., 2011).  Selective 
activation of D1-expressing neurons in the NAc is highly reinforcing (Kravitz et al., 
2012).  Thus, the circuit mechanism by which activation of D1-expressing MSNs is 
reinforcing could be through inhibition of VTA GABAergic neurons, and thus 
disinhibition of VTA dopaminergic neurons.  Although the NAc also sends a direct 
projection to dopaminergic neurons (Watabe-Uchida et al., 2012), the connection 
onto GABAergic neurons is markedly more robust and profuse (Bocklisch et al., 
2013; Xia et al., 2011).  
 
 
 
	   12	  
Amygdala and extended amygdala 
The VTA also receives a dense projection from the BNST.  Both 
glutamatergic and GABAergic neurons in the BNST project to the VTA, where they 
synapse primarily onto GABAergic VTA neurons, although they also project to 
dopaminergic neurons as well (Jennings et al., 2013a; Kudo et al., 2012).  
Interestingly, activation of these parallel circuits affects behavior in an opposing 
fashion (Jennings et al., 2013a).  Activation of the glutamatergic inputs to the VTA is 
anxiogenic and aversive, while activation of the GABAergic inputs to the VTA is 
anxiolytic, positively reinforcing, and rewarding.  Since BNST neurons project 
primarily onto GABAergic neurons in the VTA, it is thought that these opposing 
behavioral responses are due to indirect inactivation (via BNST glutamatergic 
neurons) or activation (via BNST GABAergic neurons) of VTA dopaminergic 
neurons.  
The BLA is also an important afferent to dopaminergic neurons.  Although the 
BLA does not send appreciable projections directly to the VTA, glutamatergic BLA 
neurons project to the NAc, where they modulate presynaptic dopamine release, 
likely through an axo-axonic mechanism (Howland et al., 2002).   Consistent with 
these observations, optogenetic activation of BLA glutamatergic inputs to the NAc is 
reinforcing, and dependent on dopamine signaling in the NAc (Stuber et al., 2011).   
 
Lateral Habenula 
Recently, a lot of attention has been focused on the projection from the LHb 
to the midbrain.  The LHb is a well-conserved glutamatergic epithalamic structure.  
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LHb neurons tend to fire in a manner opposite to dopaminergic neurons.  While 
dopaminergic neurons show excitations to reward-predictive cues, and inhibitions to 
cues that predict no rewards, LHb neurons show excitations to cues that predict the 
absence of rewards and are inhibited by reward-predictive cues (Matsumoto and 
Hikosaka, 2007).  LHb neurons also show excitations to aversive stimuli and the 
cues that predict them (Matsumoto and Hikosaka, 2009a).  Interestingly, the 
excitation of LHb neurons to the cue that predicts the absence of a reward precedes 
the inhibition of dopaminergic neurons, suggesting that LHb neurons are providing 
dopaminergic neurons with a negative reward signal (Matsumoto and Hikosaka, 
2007).  Since LHb neurons are primarily glutamatergic, this reward information is 
likely relayed to dopaminergic neurons via GABAergic neurons. The LHb sends a 
robust glutamatergic projection to the RMTg, a GABAergic hindbrain structure that 
directly inhibits VTA dopaminergic neurons (Jhou et al., 2009b; Matsui and Williams, 
2011), and thus the RMTg has been identified as the likely intermediary structure 
through which LHb neurons signal negative reward information to dopaminergic 
neurons (Hong et al., 2011).  However, the behavioral and functional relevance of 
this circuit is unclear, and is one of the main goals of this dissertation, as discussed 
in the Dissertation section below.   
 
Cortex 
 The VTA receives cortical afferents from the mPFC, orbital frontal cortex 
(OFC), somatosensory cortex, and cingulate cortex (Geisler et al., 2007; Sesack and 
Pickel, 1992; Watabe-Uchida et al., 2012).  The PFC projects to NAc-projecting VTA 
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GABAergic neurons and PFC-projecting VTA dopaminergic neurons (Carr and 
Sesack, 2000b).  The orbital frontal cortex sends a modest projection to the VTA 
(Watabe-Uchida et al., 2012).  No studies to date have selectively activated this 
circuit; however, an inactivation study demonstrated that both the VTA and OFC are 
necessary for learning unexpected outcomes.  Although it is possible that this could 
be mediated by an intermediary structure, it is clear that either direct or indirect 
connectivity between the VTA and OFC are necessary for reward prediction error 
(Takahashi et al., 2009).   
 
Hindbrain  
Burst firing of dopaminergic neurons results in phasic dopamine release in the 
NAc (Gonon, 1988; Overton and Clark, 1992), and is thought to be essential for 
reward prediction error.  Several studies have demonstrated that burst firing in 
dopaminergic neurons is likely driven by inputs from the mesopontine tegmentum.   
Nuclei of the mesopontine tegmentum that project to the VTA include the 
pedunculopontine (PPTg), laterodorsal (LDTg), and the RMTg.  While the RMTg is 
likely the main candidate for providing dopaminergic neurons with negative reward 
prediction error (Hong et al., 2011), the LDT and PPTg contribute to phasic burst 
firing in dopaminergic neurons (Floresco et al., 2003; Lodge and Grace, 2006a, 
2006b).  The mechanism by which the PPTg and LDT affects burst firing is unclear, 
as both of these regions send glutamatergic, cholinergic, and GABAergic projections 
to the VTA (Geisler et al., 2007; Mena-Segovia et al., 2008; Oakman et al., 1995; 
Wang and Morales, 2009; Winn et al., 1997).  LDT neurons send a glutamatergic 
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projection to NAc-projecting VTA dopaminergic neurons, and optogenetic activation 
of this projection elicits conditioned place preference, and promotes a rewarding 
phenotype that is dependent on dopamine signaling in the NAc (Lammel et al., 
2012).  Collectively, these data demonstrate that hindbrain afferents, in particular 
from the mesopontine tegmentum are a likely candidate for providing dopaminergic 
neurons with reward prediction error.  
Another prominent VTA hindbrain afferent arises from the DRN, which 
provides the majority of serotonergic input to the forebrain (Jacobs and Azmitia, 
1992).  Along with the VTA, the DRN also projects to several reward-related brain 
regions such as the NAc and PFC (Vertes, 1991).  However, the investigation of the 
role of serotonin and reward has yielded conflicting results.  For example, while 
some studies have demonstrated a positive correlation between serotonin 
neurotransmission and reward (Kranz et al., 2010), others have suggested that 
serotonin may encode aversion and oppose the actions of dopamine in reward 
(Abler et al., 2012; Schweimer and Ungless, 2010).  A recent study that selectively 
targeted serotoninergic neurons, and their projections to the VTA, demonstrated that 
activation of serotonin neurons results in a robust rewarding phenotype (Liu et al., 
2014).  DRN serotoninergic neurons also release glutamate in the VTA.  Therefore, 
it is unclear whether this appetitive phenotype is mediated by serotonin or glutamate 
release (Liu et al., 2014).  
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Unexplored circuits 
The VTA also receives several other afferents that have been yet to be 
functionally or behaviorally dissected.  These include GABAergic projections from 
the ventral pallidum, preoptic area of the hypothalamus projections, inputs from the 
superior colliculus, periaqueductal gray, and projections from several nuclei in the 
pontine, cerebellum and medulla (Geisler and Zahm, 2005). It will be important for 
future studies to continue to tease apart how each of these inputs onto VTA 
dopaminergic neurons contribute to appetitive and aversive processing of stimuli, as 
well as the subsequent generation of motivated behavioral responses.  
 
Outputs of the VTA 
In general, regions of the brain that receive input from the VTA, send 
projections back to the VTA (Geisler and Zahm, 2005; Taylor et al., 2014; Watabe-
Uchida et al., 2012).  Dopaminergic neurons in the VTA send widespread projections 
throughout the forebrain, including the mPFC, NAc, LHb BLA, and hippocampus 
(Swanson, 1982).  VTA GABAergic and glutamatergic neurons also send extensive 
connections to both overlapping VTA dopaminergic target regions, as well as distinct 
regions of the brain that receive little to no dopaminergic input.  Since dopaminergic 
neurons project to largely non overlapping regions (Ford et al., 2006; Lammel et al., 
2008; Swanson, 1982), and since dopamine appears to be involved in a variety of 
aspects of motivated behavior, it is likely that the precise role of dopamine in various 
behaviors is a function of projection target.   
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Striatum 
The most well studied dopaminergic output is to the NAc.  Along with 
dopaminergic afferents, the NAc also receives glutamatergic afferents from limbic 
regions such as the BLA, prefrontal cortex, and hippocampus.  The NAc projects to 
motor areas such as the VTA and ventral pallidum, and is thus situated to interface 
and process motivation and reward information to then promote goal directed 
behaviors (Mogenson et al., 1980). 
The study of dopamine release in the NAc using electrochemistry, and in 
particular fast scan cyclic voltammetry (FSCV), has allowed for the quantification of 
dopamine release with unparalleled temporal and spatial resolution (Phillips et al., 
2003a). In addition, these studies have complemented previous electrophysiological, 
genetic, and pharmacological studies implicating dopamine signaling in the NAc in 
appetitive and aversive behaviors (Wanat et al., 2009).  Supporting the role of 
dopamine as a teaching signal, FSCV studies have demonstrated that as a rodent 
learns to associate a reward-predictive cue with a reward, dopamine transients in 
the NAc shift from occurring during the onset of the reward, to the onset of the cue 
(Day et al., 2007).  Electrochemical studies have also demonstrated dopamine 
release in the NAc in response to novel stimuli, aversive stimuli, during sexual 
behavior, and in response to cues predicting drugs of abuse such as cocaine 
(Badrinarayan et al., 2012; Phillips et al., 2003b; Rebec et al., 1997; Robinson et al., 
2001; Stuber et al., 2005; Young et al., 1993).  
Selective activation of dopaminergic inputs to the ventral striatum is rewarding 
and drives positive reinforcement (Witten et al., 2011).  However, in light of recent 
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studies demonstrating that dopaminergic neurons can co-release both GABA and 
glutamate in the striatum (Stuber et al., 2010; Tecuapetla et al., 2010; Tritsch et al., 
2012), results from the aforementioned studies may not be exclusively attributed to 
the effects of dopamine release.  While many studies have established a central role 
for dopamine in reinforcement (Berridge and Robinson, 1998; Ikemoto and 
Panksepp, 1999; Wise, 2004), it remains unclear if the co-release of glutamate and 
GABA from dopaminergic neurons mediates aspects of reinforcement.   
 GABAergic neurons in the VTA also project to the striatum (Van Bockstaele 
and Pickel, 1995; Brown et al., 2012; van Zessen et al., 2012).  Surprisingly, these 
neurons project specifically to cholinergic interneurons, and activation of these 
inputs decreases the spontaneous firing rate of postsynaptic cholinergic neurons, 
similar to the pause seen during reinforcement training (Brown et al., 2012). When 
the authors mimicked this pause in vivo, by activating the VTA GABAergic inputs to 
the striatum, mice were better able to discriminate a salient stimulus that predicted 
an aversive event. These data demonstrate that GABAergic afferents to cholinergic 
interneurons are important in modifying behavioral responses to conditioned stimuli.  
Finally, non-dopaminergic glutamatergic VTA neurons also project to the NAc 
(Hnasko et al., 2012), but the precise function of this circuit is yet to be determined.   
 
Cortex 
Dopaminergic, GABAergic, and glutamatergic VTA neurons project to the 
mPFC (Carr and Sesack, 2000a; Swanson, 1982; Taylor et al., 2014).  And, as 
discussed above, the PFC projects back to the VTA, where it synapses onto PFC-
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projecting dopaminergic neurons and NAc-projecting GABAergic neurons (Carr and 
Sesack, 2000b).  Recent studies have suggested that the VTA-to-mPFC circuit may 
processes aversive and stressful stimuli.  mPFC-projecting VTA dopaminergic 
neurons show increases in AMPA/NMDA ratio following exposure to an aversive 
stimulus (Lammel et al., 2011).  Therefore, mPFC-projecting VTA dopaminergic 
neurons may be the neurons that are showing phasic excitations to aversive stimuli 
(Brischoux et al., 2009; Matsumoto and Hikosaka, 2009b). Interestingly, optical 
inhibition of the VTA-to-mPFC circuit in mice with a history of social defeat 
decreased social interaction, suggesting that inputs to the mPFC arising from the 
VTA may be involved in promoting aspects of depression (Chaudhury et al., 2013).  
 
Limbic regions 
VTA dopaminergic neurons also project to the hippocampus, where they 
preferentially target the subiculum, hilus, and the CA1 region (Lisman and Grace, 
2005).  The VTA-to-hippocampus circuit is thought to signal novelty and enhance 
learning.  Exposure to a novel environment increases dopamine release in the 
hippocampus (Ihalainen et al., 1999) and enhances D1-dependent long term 
potentiation in the CA1 (Li et al., 2003).  In addition, dopamine agonists in the 
hippocampus tend to enhance learning and memory (Bach et al., 1999; Bernabeu et 
al., 1997; Packard and White, 1991), while antagonists impair memory (Bernabeu et 
al., 1997; Gasbarri et al., 1996).  The VTA also receives indirect connections from 
the hippocampus through a subiculum-accumbens-ventral pallidum – VTA circuit 
(Lisman and Grace, 2005). The VTA also sends projections to parts of the amygdala 
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and extended amygdala, including the BLA, central amygdala, and BNST (Swanson, 
1982).   
While these studies demonstrate a functional circuit from the VTA to limbic 
regions, future studies are clearly needed to determine the causal role of the 
dopaminergic projection to these areas.   
 
Unexplored Circuits 
While optogenetic techniques have been employed to investigate the 
behavioral and functional role of the VTA-to-NAc and VTA-to-mPFC circuits, a 
number of dopaminergic circuits have yet to be fully defined.  Importantly, although 
the existence of a mesohabenular pathway has been identified (Gruber et al., 2007; 
Phillipson and Griffith, 1980; Skagerberg et al., 1984; Swanson, 1982), the 
behavioral or functional significance of this circuit remains unclear, which is the topic 
for the second part of this dissertation, as discussed below in the Dissertation 
section. Additionally, projection targets of VTA glutamatergic and GABAergic 
neurons of the VTA remain widely unexplored.  VTA GABAergic neurons project to 
the NAc, PFC, ventral pallidum, preoptic nuclei, LH, and LHb (Fields et al., 2007; 
Taylor et al., 2014).  VTA glutamatergic neurons project to the NAc, LHb, amygdala, 
ventral pallidum and mPFC (Hnasko et al., 2012; Taylor et al., 2014; Yamaguchi et 
al., 2011).   Interestingly, while VTA non-dopaminergic GABAergic and glutamatergic 
neurons project to areas that also receive dopaminergic innervation, they also send 
projections to areas that receive little to no dopaminergic innervation. 
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ROLE OF THE LATERAL HABENULA IN MOTIVATED BEHAVIORS  
The habenula is a bilateral epithalamic structure located on both sides of the 
third ventricle.  The habenula is subdivided into the lateral (LHb) and medial (MHb) 
portions, which are anatomically, genetically, morphologically, and functionally 
distinct (Klemm, 2004; Nair et al., 2012).  The LHb receives converging inputs from 
the cortex, basal ganglia, and limbic systems (Geisler and Trimble, 2008).  While the 
LHb sends weak projections back to a few of these regions, the primary output of the 
LHb is to midbrain monoamanergic nuclei, including the VTA and DRN (Araki et al., 
1988; Geisler and Trimble, 2008).  Electrical stimulation of the LHb inhibits midbrain 
dopaminergic neurons, while lesions of the LHb result in activation of midbrain 
dopaminergic neurons (Lisoprawski et al., 1980; Nishikawa et al., 1986).  Similarly, 
inhibition of the LHb increases dopamine release in the striatum (Lecourtier et al., 
2008). 
Seminal studies conducted in monkeys revealed that LHb neurons encode 
negative reward prediction errors (Matsumoto and Hikosaka, 2007).  While midbrain 
dopaminergic neurons show excitations to reward predictive cues and inhibitions to 
cues that predict reward omissions, LHb neurons show excitations to cues that 
predict no reward and inhibitions to reward predictive cues (Matsumoto and 
Hikosaka, 2007).  The excitation to the reward omission in the LHb neurons 
preceded the inhibition of dopaminergic firing, suggesting that the LHb is inhibiting 
midbrain dopaminergic neurons to suppress behaviors directed towards a non-
rewarding stimulus.   
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The LHb is comprised of almost entirely glutamatergic neurons (Geisler and 
Trimble, 2008), and sends projections to GABAergic neurons in the RMTg (Balcita-
Pedicino et al., 2011; Hikosaka et al., 2008), a discrete population of neurons 
posterior to the VTA, which inhibits VTA dopaminergic neurons (Matsui and 
Williams, 2011).  VTA-projecting RMTg neurons show Fos induction after exposure 
to aversive stimuli, such as foot shock and food deprivation. Collectively, these data 
suggest that the LHb negatively modulates midbrain dopaminergic neurons during 
the presentation of aversive stimuli or omission of rewards through connections with 
the RMTg.   
The LHb has also been recently implicated as a key brain nuclei in the 
pathophysiology of depression.  Neuroimaging studies have revealed increased 
activity in the habenula in models of depression in humans and rodents (Caldecott-
Hazard et al., 1988; Morris et al., 1999; Shumake et al., 2003).  A recent study 
aimed at uncovering the molecular mechanisms in the LHb mediating core 
symptoms of depression, found that increasing beta-CamKII increased synaptic 
efficacy and output of the LHb and was sufficient in producing depressive-like 
symptoms (Li et al., 2013).   
 
RELATIONSHIP BETWEEN NEURAL CIRCUITS UNDERLYING MOTIVATED 
BEHAVIORS AND NEUROPSYCHIATRIC DISEASES  
 
Disruption in dopaminergic signaling in the VTA, as well as dysfunction in 
VTA afferent and efferent connectivity, are thought to underlie aspects of addiction, 
mood disorders, attention disorders, and schizophrenia (Bonci et al., 2003; Nestler 
and Carlezon, 2006; Tye and Deisseroth, 2012).  A number of studies have 
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demonstrated that nearly every drug of abuse either directly or indirectly increases 
dopamine neurotransmission (Di Chiara and Imperato, 1988; Nestler, 2005).  
Further, both short term and long term exposures to drugs of abuse can have long 
lasting changes on dopaminergic function and afferent and efferent plasticity 
(Lüscher and Malenka, 2011).  In addition to the role of midbrain function and 
connectivity on drug addiction, recent optogenetic investigations have also 
implicated the VTA in mediating aspects of depression, as discussed above in the 
VTA Circuitry section.   
Recent studies have implicated the LHb in neuropsychiatric diseases such as 
depression (as discussed above) and drug addiction.  Drugs of abuse have both 
rewarding and aversive components, and it is thought that both the negative and 
positive reinforcing properties of drug taking contribute to drug addiction (Koob, 
2013).  In vivo electrophysiology in rats have demonstrated that exposure to cocaine 
produces biphasic responses in aversive-responding LHb neurons (Jhou et al., 
2013).  LHb neurons showed initial inhibition to intravenous cocaine, followed by 
delayed excitation, mirroring the shift from the rewarding to aversive aspects of 
cocaine.  Lesions of LHb efferents, lesions of the RMTg, and optogenetic inhibition 
of the RMTg all abolished cocaine-induced avoidance behaviors (Jhou et al., 2013).     
 
OVERVIEW OF OPTOGENETICS 
Determining causal relationships between neural function and behavior is 
crucial to understand the neuropathology underlying neuropsychiatric diseases.  As 
reviewed above, both the LHb and VTA have been implicated in a number of 
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neuropsychiatric diseases, and thus I utilized a novel technique called optogenetics 
to investigate the functional and behavioral significance of the reciprocal connectivity 
between the LHb and VTA.  Because this technique is used throughout all of the 
subsequent chapters, below I have outlined the technical aspects of optogenetics, 
as well as in vitro and in vivo applications.  Further, at the end of this dissertation I 
discuss a few of the important limitations and considerations associated with 
optogenetic experiments.   
The functional complexity and genetic heterogeneity of the brain has 
historically prevented researches from investigating the causal link between neural 
circuits and behavior.  Relationships between function and behavior have 
traditionally been accomplished by tissue lesioning techniques, electrical stimulation, 
or pharmacological activation or inactivation.  Whereas these methods have 
uncovered the basic neuroanatomical pathways that mediate reward-related 
behavior, they often fail to determine pathway or genetic specificity mediating a 
behavioral response.  Site-directed pharmacological manipulations can sometimes 
be used to address genetically defined pathways (if only a given population of 
neurons locally express a specific receptor), but these manipulations are often over 
longer timescales, which do not allow for determining how neural activity is required 
for discrete behavioral events, which can often times last for less than 1 s. To 
investigate causal relationships between genetically defined populations of neurons 
and reward-seeking behavior, techniques allowing for precise control of neural 
circuitry with millisecond precision are required.  Optogenetics allows for pathway-
specific manipulation of brain circuitry over a range of timescales, which circumvents 
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many of the technical limitations associated with electrical, lesioning, and 
pharmacological manipulations.  Finally, combining optogenetics with slice 
electrophysiology and in vivo behavioral paradigms allows for an unprecedented 
insight into the neural circuitry involved in motivated behaviors.  
 
Opsins and hardware to control specific neuronal pathways with light 
For a full description of the different opsins currently used to study neural 
circuits see Yizhar et al. (Yizhar et al., 2011a).  The most commonly used opsin to 
activate neural circuits is channelrhodopsin (ChR2). ChR2 is a light-gated cation 
channel that was originally isolated from blue-green algae (Nagel et al., 2003). ChR2 
is maximally activated by a blue, 450-490 nm light.  When activated, absorbed 
photons cause a light-induced isomerization of the all-trans retinal protein, which 
opens the channel allowing sodium and other cations to flow through the cell.  When 
expressed in a neuron, this influx of cations causes depolarization of the cell 
membrane at resting membrane potentials, which will lead to the opening of 
endogenously expressed voltage-gated sodium channels to initiate an action 
potential.  
Optogenetic inactivation of neural circuits is most commonly accomplished 
using the light gated chloride pump, halorhodopsin (NpHR), which was first 
discovered in arachabacteria (Matsuno-Yagi and Mukohata, 1977).  Introduction of 
wildtype NpHR into neurons demonstrated that while photoinhibition was possible, 
exogenous NpHR protein was not initially sufficiently expressed at neuronal 
membranes for consistent results in vivo (Gradinaru et al., 2010).  Further 
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modification of NpHR, with an added endoplasmic reticulum export signal and 
membrane trafficking peptide sequence, results in robust expression at neuronal 
membranes, which facilitated its use in vivo for neuronal circuit element inhibition 
(Gradinaru et al., 2010).  NpHR is maximally activated by a yellow/orange, ~590 nm 
wavelength of light, but can response to a broad wavelength range from ~520 – 620 
nm.  When activated, NpHR pumps chloride from the extracellular space into the 
cytoplasm of the cell.  When expressed in a neuron, this results in hyperpolarization 
of the cell membrane, and can decrease neuronal firing rates (Fenno et al., 2011).  
Optical inhibition can also be achieved by the use of outward proton pumps, such as 
archaerhodopsin (Arch) (Fenno et al., 2011).  Arch is maximally activated by a 560 
nm wavelength of light, and activation of Arch has been shown to result in robust 
currents at relatively low light outputs (Chow et al., 2010).  Although proton pumps 
such as Arch show robust inhibition of neuronal membranes, it remains 
undetermined the deleterious effects these proteins have in neuronal tissues and if 
they show any non cell-type specific effects (Fenno et al., 2011). 
Expressing opsin proteins under the control of cell type specific promoters is 
one method of targeted manipulations of genetically defined neuronal subtypes.  
Using this technique, optogenetic manipulation of glutamatergic BLA neurons to the 
NAc have been investigated (Stuber et al., 2011). Calcium-calmodulin-dependent 
protein kinase IIα (CamKIIα) is preferentially expressed in glutamatergic projection 
neurons in the BLA (McDonald, 1992).  ChR2 or NpHR3.0 was introduced into these 
glutamatergic neurons using an adeno-associated virus (AAV) vector with ChR2 
under the control of a CamKIIα promoter. Stereotaxic injection of this construct into 
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the BLA results in ChR2 positive neurons constrained to glutamatergic projection 
neurons within the BLA.  As discussed in detail below, implantation of an optical fiber 
into the NAc, allows for precise control over excitatory BLA inputs into the NAc.  
Other studies using the CamKIIα promoter have investigated BLA afferents to other 
regions of interest such as the central amygdala (Tye et al., 2011) and to study 
cortical pyramidal neurons (Aravanis et al., 2007; Sohal et al., 2009; Yizhar et al., 
2011b). 
A transgenic approach is also a common method to achieve targeted 
manipulation of genetically defined cells.  There now exist a number of transgenic 
mouse lines that selectively express ChR2 or NpHR in specific subtypes of neurons 
(Arenkiel et al., 2007; Zhao et al., 2011).  Whereas this method ensures that virtually 
all neurons of a specific genetically defined population will express opsin proteins, it 
oftentimes do not provide anatomical specificity of expression to a discrete brain 
region of interest.  Thus, to reliably target neuronal populations within specific brain 
nuclei, cre recombinase-inducible expression systems have been used in 
conjunction with transgenic animals expressing cre in specific populations of 
neurons.  Using this method, cre-inducible opsins are stereotaxically injected into 
transgenic mice expressing cre recombinase in genetically identified neuronal 
populations (Atasoy et al., 2008; Cardin et al., 2009; Sohal et al., 2009; Tsai et al., 
2009; Witten et al., 2011). Cre-inducible AAV vectors contain DNA cassettes with 
two pairs of incompatible lox sites (LoxP and lox2722) with an opsin inserted 
between the two lox sites in the reverse orientation.  Cre recombinase catalyzes 
recombination between the two lox sites, resulting in the opsin reversing its 
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orientation, allowing the opsin to be transcribed.  Thus, delivery of these cre-
inducible opsins into a specific brain region results in opsin expression in only the 
genetically identified cell-type in the brain region of interest.  Cholinergic 
interneurons in the NAc have been targeted using this method (Witten et al., 2010).  
Here, bacterial artificial chromosome (BAC) transgenic Choline Acetyltransferase 
(ChAT)::Cre mice are injected with a cre-inducible double floxed recombinant AAV 
vector coding for ChR2 or NpHR3.0 into the NAc.    Dopaminergic neurons in the 
VTA have also been targeted using a transgenic approach in which TH-cre (Tsai et 
al., 2009) in mice or rats (Witten et al., 2011) or DAT-cre mice (Cohen et al., 2012; 
Stuber et al., 2010) are injected with a double floxed cre-inducible opsin vector. The 
use of cre-mice paired with double-floxed opsins, or the use of cell-type promoters, 
allows for precise control over genetically defined populations of neurons.  
Different hardware setups have been utilized to deliver light in vitro and in 
vivo.  The most common in vitro light delivery systems include filtered light from 
mercury arc lamps (Boyden et al., 2005; Gunaydin et al., 2010), lasers, (Cardin et 
al., 2010; Kravitz et al., 2012), and LEDs (Adesnik and Scanziani, 2010; Wang and 
Morales, 2009). In vivo, lasers coupled to optical fibers are most commonly used to 
deliver light into the brain (Cardin et al., 2010; Stuber et al., 2011; Tye et al., 2011).  
For a more in depth description of in vivo light delivery to the brain, see the section 
entitled In Vivo Optogenetic Strategies. 
 Finally, interfacing lasers with behavioral equipment allows for optogenetics to 
be employed in a wide-range of reward-related behavioral paradigms including 
conditioned place preference (Lobo et al., 2010; Tsai et al., 2009), operant 
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conditioning (Adamantidis et al., 2011) and Pavlovian conditioning (Stuber et al., 
2011).  Combining these paradigms with optogenetics allows for sub second 
precision control of neural circuitry time locked to discrete behavioral events.  
Behavioral paradigms associated with other neuropsychiatric diseases, such as 
open field test and elevated plus maze, have also been interfaced with in vivo 
optogenetics (Tye et al., 2011).  This can be achieved using real-time video tracking 
hardware and software to restrict optical stimulation when the animal enters a 
specific area of a behavioral arena.  
 
Slice electrophysiology paired with optogenetics to parcel out local circuits 
 Anatomical tracing studies and electrophysiological techniques using 
electrical stimulation are often used to study the synaptic connectivity within neural 
circuits.  However, there are significant limitations associated with both of these 
techniques.  Anatomical tracing studies often fail to address the strength and 
functionality of the synaptic connections.  Electrophysiological studies using 
electrical stimulation can address functionality, but they often fail to determine cell-
type specific projections. Because of the heterogeneity of most neural tissues, 
electrical stimulation will typically non-specifically activated all afferents to a given 
neuron.  Patch clamp electrophysiology paired with optogenetics circumvents the 
limitations associated with both of these methods because it allows for cell-type 
specific activation and assessment of the strength and functionality of these 
connections.  Using this method, it is possible to record from postsynaptic neurons 
(using mice expressing fluorescent proteins in specific neurons or by post hoc 
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immunohistochemistry), while optically stimulating site-specific or genetically defined 
afferents that are expressing ChR2.  These techniques have been successful in 
parsing out neural circuits involved in addiction.  In one example of this application, 
Chuhma et al (2011) used optogenetics in NAc brain slices to define the functional 
connectivity of MSNs.  By conditionally expressing ChR2 in MSNs, these authors 
were able to investigate connections within the striatum and projections to the 
globus pallidus and substantia nigra (Chuhma et al., 2011), as well as examine how 
striatal cholinergic interneurons can regulate function of other populations of striatal 
neurons.  
Optogenetics paired with slice electrophysiology has also been used to 
examine the possibility of neurotransmitter co-release.  Dopamine and glutamate 
coincident signaling is crucial for a variety of motivated behaviors including 
responding to motivationally significant stimuli.  A subset of TH positive 
dopaminergic neurons in the VTA also express vesicular glutamate transporter-2 
(VGluT2), indicating that these dopaminergic neurons are capable of packaging 
glutamate into synaptic vesicles (Hnasko et al., 2010). Furthermore, 
pharmacological and electrophysiological studies have suggested that dopaminergic 
neurons co-release glutamate (Bourque and Trudeau, 2000; Chuhma et al., 2009; 
Sulzer et al., 1998); however, these studies only provided indirect evidence as a 
result of the technical limitations.  Selective optogenetic stimulation of ChR2-positive 
dopaminergic terminals in the NAc shell results in excitatory postsynaptic currents 
(Stuber et al., 2010; Tecuapetla et al., 2010), confirming that midbrain dopaminergic 
neurons are capable of co-releasing glutamate in the NAc.  Similar studies have now 
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confirmed that other neurons that release neuromodulators, such as acetylcholine, 
are also capable of glutamate corelease, such as projection neurons in the MHb 
(Ren et al., 2011).  Utilizing optogenetic approaches to study neurotransmitter 
release will likely yield a plethora of novel information on the intraneuronal signaling 
dynamics of defined neural circuits.   
 
In vivo optogenetic strategies  
In vivo optogenetic approaches can be used for a variety of different 
experiments from targeted manipulations of genetically defined cells to manipulation 
of specific neural pathways on a physiologically relevant time-scale.  Furthermore, 
utilizing these in vivo optogenetic approaches in awake and behaving animals allows 
for precise control over neural circuitry time locked to discrete events, necessary for 
determining a causal relationship between structure and cue or reward-related 
behavior.  
Delivering light into the brain is most often accomplished by implanting an 
acute or chronic optical fiber into the region of interest (Sparta et al., 2012; Zhang et 
al., 2010).  Using the acute optical fiber method, a guide cannula is chronically 
implanted in either the virus-targeted region or the projection region of interest.  
Then, the optical fiber is acutely implanted immediately prior to the experiment.  One 
benefit of employing an acute fiber is the ability to combine local pharmacology 
through the cannula before implantation of the fiber. However, a major caveat to this 
method is the risk of tissue damage and fiber breakage due to repeated insertion 
and removal of the fiber.  This is especially of concern when working with behavioral 
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paradigms that involve weeks of training and testing. Chronic fibers, on the other 
hand, are cemented into the skull during stereotaxic surgery and allow for multiple 
testing sessions over an extended time period with minimal light loss (Sparta et al., 
2012). 
Chronic or acute optical fibers can be placed in the same brain area as the 
virus injection to examine the effects of optical stimulation or inhibition on genetically 
targeted cell bodies of interest.  For example, optical activation of D2 positive 
neurons in the NAc expressing ChR2 suppresses cocaine reward, while activation of 
D1 positive neurons increases cocaine reward (Lobo et al., 2010).  Optical fibers can 
also be placed in projection targets to investigate the effects of altering pathway-
specific circuits on behavior.  Opsins are trafficked across the membrane and a few 
weeks after transduction of cell bodies, opsins tagged to fluorescent proteins can be 
visualized in axons and terminals (Yizhar et al., 2011a).  This technique has mainly 
been employed to look at BLA afferent projections to different brain regions (see 
below) (Stuber et al., 2011; Tye et al., 2011), but can be utilized to look other neural 
circuits important in addiction such as dopaminergic afferents in the NAc and mPFC.  
In addition, this strategy can identify neural circuit elements or genetically defined 
populations of neurons that are necessary or sufficient for a discrete behavior such 
as conditioned approach behavior to a reward-predictive cue.  For example, BLA 
glutamatergic afferents to the NAc have been hypothesized to be important in cue-
triggered motivated behavior, but because of the inability to specifically modulate 
this pathway during time-locked cues, the causal functional role of this pathway in 
cue-reward behavior was preciously not well defined.  Using optogenetics, activation 
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and inactivation of BLA terminals in the NAc demonstrated that this circuitry is both 
necessary and sufficient for cue-driven motivated behavior (Stuber et al., 2011). 
Optogenetic manipulations of the neural circuitry involved in motivated 
behaviors have aided in supporting and refuting many hypotheses that were 
previously untestable as a result of technical limitations associated with traditional 
techniques.  Many of the optogenetic studies to date investigating these circuits 
have used optogenetic stimulation of neurons, but optogenetic inhibition is likely to 
prove to be an even more powerful tool to determine both necessity and sufficiency 
of neural circuits for mediating reward-related behaviors.  In addition, combining 
optogenetics with in vivo monitoring techniques such as in vivo electrophysiology, 
and neurochemical techniques such as microdyalisis and voltammetry, allows for 
actuation of neural circuits, while simultaneously measuring the neurophysiological 
output.  The ever-increasing methods for targeted genetic manipulations of neurons 
as well as the continued development and refinement of optogenetic methods are 
unprecedented.  
 
DISSERTATION 
Neurons in the LHb are excited by aversive stimuli and are thought to inhibit 
midbrain dopaminergic neurons during the presentation of an aversive stimulus or 
the omission of a reward through synapses onto RMTg neurons.  However, little is 
known about the electrophysiological properties of LHb excitatory inputs onto 
postsynaptic neurons in the RMTg.  Further, although correlative evidence suggests 
that the LHb neurons convey anti-reward and aversive information, the behavioral 
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consequences of LHb-to-RMTg activation remain unknown.  To address this, I use 
ex vivo and in vivo optogenetic strategies to investigate how aversive stimuli alter 
LHb-to-RMTg glutamatergic transmission and how direct manipulation of this 
pathway affects behavior.    
Following thorough investigation of the LHb-to-midbrain circuit I next 
investigated various LHb afferents.  Inputs to the LHb arise from forebrain regions 
including the LH, entopenduncular nucleus (EN) and prefrontal cortex (Kim and Lee, 
2012; Poller et al., 2013; Shabel et al., 2012; Warden et al., 2012).  Although the 
majority of LHb afferents arise from the forebrain, the LHb also receives a 
substantial projection from the VTA, with an estimated 30-50% of LHb-projecting 
VTA neurons being dopaminergic (Gruber et al., 2007; Phillipson and Griffith, 1980; 
Skagerberg et al., 1984).  Electrical stimulation of the midbrain decreases the firing 
rate of LHb neurons (Shen et al., 2012), but the functional and behavioral 
significance of synaptic inputs to the LHb arising from VTA dopaminergic neurons 
remains unknown.  I utilized a combination of optogenetic manipulations, 
electrophysiology, and viral tracing techniques to investigate the molecular, 
anatomical, and genetic profiles of LHb-projecting VTA dopaminergic neurons.  I 
next used electrophysiology combined with electrochemical techniques to determine 
which neurotransmitters these dopaminergic neurons release in the LHb, and how 
this connection affects downstream reward circuitry.  Finally, I combined 
optogenetics with behavior to determine the behavioral significance of this circuit.    
In the last aim of this dissertation I investigated another LHb afferent from the 
LH.  The LH is involved with promoting behaviors to maintain homeostasis, such as 
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reward-seeking and feeding.  The LHb receives a robust glutamatergic projection 
from the LH (Poller et al., 2013), and thus may serve as a prominent connection 
between homeostatic and reward circuits. However, the precise function of this 
circuit is unclear.  To investigate this, I utilized optogenetics in combination with a 
genetic ablation method to determine the behavioral and functional relevance of this 
circuit.    
Collectively, data generated from these aims will increase our understanding 
of the neural circuits involved in processing aversive and rewarding stimuli, and may 
aid in the identification of novel targets for the treatment of addiction and other 
neuropsychiatric diseases.  
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CHAPTER 2: ACTIVATION OF LATERAL HABENULA INPUTS TO THE 
VENTRAL MIDBRAIN PROMOTES BEHAVIORAL AVOIDANCE2 
 
INTRODUCTION 
The neural circuitry that mediates behavioral responses to rewarding and 
aversive stimuli become disrupted in neuropsychiatric diseases such as drug 
addiction, anxiety disorders, and depression (Koob and Volkow, 2010; Shin and 
Liberzon, 2010). Ventral tegmental area (VTA) dopaminergic neurons show changes 
in firing patterns in response to both rewarding and aversive associated stimuli 
(Brischoux et al., 2009; Schultz et al., 1997). While dopaminergic neurons encode 
salient stimuli and predictive cues, the neural circuit elements that provide dopamine 
neurons with reward- and aversive-related information are not well defined.  
The lateral habenula (LHb) has been shown to signal punishment and 
prediction errors, as LHb neurons are excited by aversive stimuli and inhibited by 
rewarding stimuli (Bromberg-Martin and Hikosaka, 2011).  In addition, excitatory 
inputs to LHb neurons are potentiated in a learned helplessness model of 
depression (Li et al., 2011).  The LHb sends excitatory projections to GABAergic 
neurons in midbrain limbic structures such as the VTA and rostromedial tegmental 
nucleus (RMTg) (Jhou et al., 2009b; Matsui and Williams, 2011; Perrotti et al., 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  2This chapter previously appeared as an article in the journal Nature Neuroscience.  
The original citation is as follows: Stamatakis, A.M., and Stuber, G.D. (2012) 
Activation of lateral habenula inputs to the ventral midbrain promotes behavioral 
avoidance. Nature Neuroscience.  8. 1105-1107. 
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2005), which act to inhibit dopaminergic neuron output (Ji and Shepard, 2007; van 
Zessen et al., 2012).  While correlative evidence suggests that the LHb neurons 
convey negative reward-related information, whether selective activation of LHb 
efferents to the midbrain has behaviorally relevant consequences remains elusive.  
Here, we used ex vivo and in vivo optogenetic strategies to investigate whether 
neurotransmission at LHb-to-RMTg glutamatergic synapses is altered by acute 
exposure to unpredictable aversive stimuli, and how direct manipulation of this 
pathway affects behavior.  
METHODS 
Experimental subjects and stereotaxic surgery 
We grouped housed adult (25–30 g) male C57BL/6J mice (Jackson 
Laboratory) until surgery. We anesthetized the mice with ketamine (150 mg per kg of 
body weight) and xylazine (50 mg per kg) and placed the mice in a stereotaxic frame 
(Kopf Instruments). We bilaterally microinjected 0.4 µl of purified and concentrated 
adeno-associated virus (AAV, ~1012 infections units per ml, packaged and titered by 
the UNC Vector Core Facility) into the LHb (coordinates from bregma: −1.7 
anterior/posterior, ±0.48 medial/lateral, −3.34 dorsal/ventral). LHb neurons were 
transduced with virus encoding ChR2-EYFP or EYFP under the control of the human 
synapsin (SYN1) promoter. Following surgery, we individually housed the mice. For 
behavioral experiments, we also implanted mice with a unilateral chronic fiber 
directed above the RMTg (coordinates from bregma: −3.9 AP, ±0.3 ML, −4.8 DV). 
We performed all experiments 6–8 weeks after surgery. We conducted all 
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procedures in accordance with the Guide for the Care and Use of Laboratory 
Animals, as adopted by the US National Institutes of Health, and with approval of the 
UNC Institutional Animal Care and Use Committees. 
Histology, immunohistochemistry and microscopy 
We anesthetized mice with pentobarbital and killed them by perfusion with 
phosphate-buffered saline followed by 4% paraformaldehyde (wt/vol) in phosphate-
buffered saline. We subjected 40-µm brain sections to immunohistochemical staining 
for neuronal cell bodies and/or tyrosine hydroxylase (Pel Freeze, made in sheep; 
Neurotrace: Invitrogen, 640-nm excitation/660-nm emission or 435-nm 
excitation/455-nm emission) as previously described (van Zessen et al., 2012).  We 
mounted sections and captured z stack and tiled images on a Zeiss LSM Z10 
confocal microscope using a 20× or 63× objective. For determination of optical fiber 
placements, we imaged tissue at 10× on an upright fluorescent microscope. We 
recorded optical stimulation sites as the location in tissue where visible optical fiber 
tracks terminated. 
Slice preparation for patch-clamp electrophysiology 
We prepared brain slices for patch-clamp electrophysiology as previously 
described (Stuber et al., 2011; van Zessen et al., 2012).  Briefly, we anesthetized 
mice with pentobarbital and perfused transcardially with modified artificial 
cerebrospinal fluid. We then rapidly removed the brains and placed them in the 
same solution that we used for perfusion at ~0° C. We cut sagittal midbrain slices 
containing the RMTg (200 µm) or horizontal midbrain slices containing the VTA and 
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RMTg (200 µm) on a vibratome (VT-1200, Leica Microsystems), placed the slices in 
a holding chamber and allowed them to recover for at least 30 min before recording. 
Patch-clamp electrophysiology 
We made whole-cell voltage-clamp recordings of RMTg neurons as 
previously described (Stuber et al., 2011). Briefly, we back-filled patch electrodes 
(3.0–5.0 MΩ) for current-clamp recordings, with a potassium-gluconate internal 
solution (van Zessen et al., 2012). For voltage-clamp recordings, we back-filled 
patch electrodes with a cesium methanesulfonic acid internal solution (Stuber et al., 
2010). For optical stimulation of EPSCs, we used light pulses from an LED coupled 
to a 40× microscope objective (1-ms pulses of 1–2 mW, 473 nm) to evoke 
presynaptic glutamate release from LHb projections to RMTg. For mEPSCs and 
optically evoked EPSCs, we voltage-clamped RMTg neurons at −70 mV. For AMPA 
and NMDA receptor experiments, the holding potential was +40 mV. We added 
picrotoxin (100 µM) to the external solution to block GABAA receptor–mediated 
inhibitory postsynaptic currents for all experiments. For mEPSCs, we added 
tetrodotoxin (500 nM) to the external solution to suppress action potential driven 
release. We calculated the AMPA/NMDA ratio and paired pulse ratio as previously 
described18. We averaged six sweeps together to calculate both the AMPA/NMDA 
ratio and the paired pulse ratio. We collected mEPSCs for 5 min or until 300 
mEPSCs were collected. To determine where, anterior-posterior, midbrain neurons 
were light responsive, we injected TH-IRES-GFP mice with SYN1-ChR2-EYFP into 
the LHb. We voltage-clamped (–70mV) GFP-positive (tyrosine hydroxylase positive) 
and GFP-negative (tyrosine hydroxylase negative) midbrain neurons and 
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categorized the cells as light-responsive if a light pulse resulted in an average 
evoked current across six sweeps of >20 pA. 
Shock procedure for patch-clamp electrophysiology 
We placed mice expressing ChR2-EYFP in the LHb-to-RMTg pathway into 
standard mouse behavioral chambers (Med Associates) equipped with a metal grid 
floor capable of delivery foot shocks for 20 min. Mice received either 19 or 0 
unpredictable foot shocks (0.75 mA, 500 ms). We presented shocks with a pseudo-
random interstimulus interval of 30, 60 or 90 s. We anesthetized mice for patch-
clamp electrophysiology 1 h after the session ended (described above). 
In vivo optogenetic excitation 
For all behavioral experiments, we injected mice with a ChR2-EYFP or EYFP 
virus and implanted them with a chronic unilateral custom-made optical fiber 
targeted to the RMTg as described previously (Sparta et al., 2012). We connected 
mice to a 'dummy' optical patch cable 3 d before the experiment each day for 30–60 
min to habituate them to the tethering procedure. Following the tethering procedure, 
we then ran mice in the behavioral procedures (see below). We used a 10-mW laser 
with a stimulation frequency of 60 Hz and a 5-ms light pulse duration for all 
behavioral experiments. 
Real-time place preference 
We placed mice in a custom-made behavioral arena (50 × 50 × 25 cm black 
plexiglass) for 20 min. We assigned one counterbalanced side of the chamber as the 
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stimulation side. We placed the mouse in the nonstimulated side at the onset of the 
experiment and delivered a 60-Hz constant laser stimulation each time the mouse 
crossed to the stimulation side of the chamber until the mouse crossed back into the 
nonstimulation side. We recorded behavioral data via a CCD camera interfaced with 
Ethovision software (Noldus Information Technologies). We defined an escape 
attempt as each time a mouse attempted to climb out of the apparatus. We only 
scored an attempt if no paws were on the ground. 
Conditioned place preference 
The conditioned place preference apparatus (Med Associates) consisted of a 
rectangular cage with a left black chamber (17 cm × 12.5 cm) with a vertical metal 
bar floor, a center gray chamber (15 cm × 9 cm) with a smooth gray floor and a right 
white chamber (17 cm × 12.5 cm) with a wire mesh floor grid. We monitored mouse 
location in the chamber using a computerized photo-beam system. The conditioned 
place preference test consisted of 4 d. Day 1 consisted of a preconditioning test that 
ensured that mice did not have a preference for one particular side20. On days 2 
and 3, we placed the mice into either the black or white side of the chamber 
(counterbalanced across all mice) and delivered either 0.5 s of 60-Hz stimulation 
with an interstimulus interval of 1 s for 20 min, or no stimulation. Approximately 4 h 
later, we placed the mice into the other side of the chamber and the mice received 
the other treatment. We placed the mice back into the chamber 24 h after the last 
conditioning session with all three chambers accessible to assess preference for the 
stimulation and nonstimulation paired chambers. To assess long-term associations 
between the stimulation and context, we placed the mice back in the chambers 7 d 
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later. 
Negative and positive reinforcement procedures 
Behavioral training and testing occurred in mouse operant chambers 
interfaced with optogenetic stimulation equipment as described previously (Sparta et 
al., 2012). For the negative reinforcement procedure, we placed mice into the 
chamber and delivered 500 ms of 60-Hz optical stimulation with an interstimulus 
interval of 1 s. We trained mice on a fixed ratio (FR1) training schedule, in which 
each nose poke resulted in 1 20-s period in which the laser was shut off and the 
LHb-to-RMTg pathway was not optogenetically activated. In addition, a tone and 
houselight cue turned on for the entire 20 s and turned off when the laser stimulation 
returned. For the positive reinforcement procedure, we food restricted a separate 
group of mice to 90% of their free-feeding bodyweight. We then trained mice for one 
session per day for 1 h in the operant chambers on a FR1 schedule (in which each 
nose poke resulted in 20 µl of a 15% sucrose solution, wt/vol). In addition, a tone 
and houselight cue turned on for 2 s. Once the mice reached stable behavioral 
responding (as determined by 3 d of over 100 active nose pokes that did not vary by 
more than 20% from the first of the 3 d), mice received 2 s of 60-Hz optical 
stimulation time-locked to the cue following each active nose poke. For both 
behaviors, we recorded inactive nose pokes, but these had no programmed 
consequences. In addition, we collected and time-stamped the number of active and 
inactive nose pokes. 
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Data analysis 
We used t tests and one- or two-way analyses of variance to analyze all 
behavioral and electrophysiological data when applicable. When we obtained 
significant main effects, we performed Tukey's HSD post hoc tests for group 
comparison. For all behavioral experiments, we analyzed the data in Ethovision, 
Matlab, Excel and Prism. We used six mice per group for the real-time place 
preference and negative reinforcement experiments and eight mice per group for the 
conditioned place preference and positive reinforcement experiments. We used no 
more than two neurons from a given animal for patch-clamp electrophysiology in the 
aversive stimuli exposure experiments. 
RESULTS 
Optogenetic Targeting of LHb Neurons and Innervation to the RMTg 
To selectively activate LHb efferents to the RMTg, we introduced 
channelrhodopsin-2 fused to an enhanced yellow fluorescent protein (ChR2-eYFP) 
in the LHb of mice using viral methods (Figure 2.1 A-C). We observed LHb terminal 
expression of ChR2-eYFP in midbrain structures, including the VTA and RMTg 
(Figure 2.1 D-F).  Whole cell recordings from RMTg neurons in brain slices revealed 
that light pulses, to selectively stimulate LHb ChR2-expressing efferent fibers, 
resulted in inward currents that were blocked by the glutamatergic receptor 
antagonist DNQX (Figure 2.1 G,H).  
We then determined the anterior-posterior distribution of LHb-to-midbrain 
functional connectivity by recording from dopaminergic and non-dopaminergic 
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neurons following optical stimulation of LHb efferents in th-ires-GFP transgenic mice. 
Fibers originating from the LHb were predominantly localized to the posterior VTA 
and RMTg and the majority of light-responsive neurons were non-dopaminergic 
neurons located in the RMTg and posterior VTA (Figure 2.1 E,I,J).  
Acute unpredictable foot shock exposure enhances LHb-to-RMTg glutamate 
release  
Since neurotransmission by LHb neurons may encode information related to 
aversive stimuli processing (Matsumoto and Hikosaka, 2009a), we explored whether 
exposure to an aversive stimulus altered excitatory neurotransmission at LHb-to-
RMTg synapses. We exposed mice expressing ChR2-eYFP in LHb-to-RMTg fibers 
to either 0 or 19 unpredictable foot shocks in a single 20-min session. One hour 
later, we performed whole-cell recordings from RMTg neurons in close proximity to 
LHb-to-RMTg ChR2-eYFP-positive fibers. Voltage clamp recordings from RMTg 
neurons from foot shock-exposed mice displayed an increase in the frequency of 
miniature excitatory postsynaptic currents (mEPSCs) compared to non-shocked 
controls (Figure 2.2 A-C). Furthermore, LHb-to-RMTg glutamate release probability 
was significantly enhanced following shock exposure, as indexed by a reduction in 
the optically-evoked paired pulse ratio (Figure 2.2 D,E).  We observed no 
differences in mEPSC amplitude or optically-evoked AMPA/NMDA ratios, 
measurements of postsynaptic glutamate receptor number or function (Figure 2.2 
A,C,F,G). These data suggest that aversive stimuli exposure enhances presynaptic 
transmission from LHb inputs to RMTg neurons. 
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Activation of LHb inputs to the RMTg produces active, passive, and 
conditioned behavioral avoidance 
To determine whether optogenetic stimulation of LHb-to-RMTg fibers has 
behavioral consequences, we optogenetically stimulated this pathway in behaving 
mice at 60-Hz as this was the mean light-evoked firing rate of LHb neurons in brain 
slices (Figure 2.1 B,C).  To determine if optogenetic stimulation of LHb-to-RMTg 
fibers resulted in passive avoidance behavior, we tested mice in a real-time place 
preference chamber.  When an experimental mouse crossed over into a counter-
balanced stimulated-designated, contextually indistinct side of an open field, light 
stimulation was constantly pulsed until the mouse crossed back into the non-
stimulated designated side.  Mice expressing eYFP spent equal times on both sides 
of the chamber, whereas mice expressing ChR2-eYFP spent significantly less time 
on the stimulated side (Figure 2.3 A,B) and made significantly more escape 
attempts (Figure 2.3 C).  There were no differences in total distance traveled or 
average velocity between ChR2-eYFP and eYFP mice across the entire session 
(Figure 2.3 D,E).  These data suggest that acute activation of LHb-to-RMTg fibers 
promotes location-specific passive avoidance behavior. 
While activation of the LHb-to-RMTg pathway induced acute avoidance, we 
next determined if activation of this pathway produced conditioned avoidance using 
a standard nonbiased conditioned place preference paradigm. 24 hrs after the last 
conditioning session, where optogenetic stimulation was paired with a distinct 
context, ChR2-eYFP-expressing mice showed a significant conditioned place 
aversion for the stimulation-paired chamber, while the eYFP-expressing mice 
showed no preference or aversion (Figure 2.3 F).  This conditioned place aversion 
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was maintained in the ChR2-eYFP-expressing mice 7 days following the last 
conditioning session (Figure 2.3 G) demonstrating that activity in this pathway also 
promotes conditioned avoidance. To determine if mice would perform an operant 
response to actively avoid activation of LHb-to-RMTg fibers, ChR2-eYFP or eYFP 
expressing mice were placed in chambers where they could nose-poke to terminate 
optogenetic stimulation of LHb-to-RMTg fibers (Figure 2.4 A).  ChR2-eYFP-
expressing mice learned to nose-poke to terminate laser stimulation over 3 daily 
training sessions (Figure 4 B,C).  Following training, ChR2-eYFP-expressing mice 
made significantly more active nose-pokes to terminate LHb-to-RMTg activation 
compared to eYFP-expressing mice (Figure 4 D,E), resulting in a significant 
increase in the percentage of time the stimulation was off (percent time stimulation 
was off: ChR2-eYFP: 47.5 ± 7.1 %; eYFP: 2.8 ± 0.9 %; t(10) = 6.28, p < 0.0001). 
These data demonstrate that LHb-to-RMTg activity can negatively reinforce 
behavioral responding. 
Next, we examined whether LHb-to-RMTg activation disrupted positive 
reinforcement. We trained a separate group of mice to nose-poke to earn liquid 
sucrose rewards. Following stable responding, nosepokes to earn sucrose in 
subsequent test sessions where paired with a 2s, 60-Hz LHb-to-RMTg stimulation 
(Figure 2.5 A).  ChR2-eYFP-expressing mice receiving stimulations made 
significantly fewer nose-pokes compared to eYFP-expressing mice and took 
significantly longer to retrieve and consume the rewards (Figure 2.5 B-G).  
Importantly, there were no significant differences between the two groups in the 
session prior when nosepokes were not paired with LHb-to-RMTg stimulation (t(14) 
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= 1.64, p = 0.12), suggesting that stimulation of this pathway time-locked to an 
operant response served as a punishment. 
 
DISCUSSION 
We found that activation of LHb terminals in the RMTg promotes active, 
passive, and conditioned behavioral avoidance, suggesting that endogenous activity 
of LHb glutamatergic inputs to the RMTg conveys information related to aversion. 
The data presented here suggest that the LHb’s connection with midbrain GABA 
neurons is crucial for promoting these behaviors. Consistent with this, direct 
excitation of VTA GABA neurons disrupts reward-related behaviors (van Zessen et 
al., 2012) and stimulation of VTA GABA neurons or inhibition of VTA dopamine 
neurons promotes aversion (Tan et al., 2012). Importantly, optogenetic stimulation of 
LHb terminals in the RMTg suppressed positive reinforcement and supported 
negative reinforcement, demonstrating this pathway can bidirectionally effect the 
same behavioral response (nose-poking) depending on the task. Dopamine 
signaling in the nucleus accumbens (NAc) promotes positive reinforcement (Koob 
and Volkow, 2010; Schultz et al., 1997). Thus, motivated behavior to suppress 
activation of the LHb-to-RMTg pathway may also depend on dopamine signaling in 
the NAc. Although encoding negative consequences requires multiple neural 
circuits, activation of glutamatergic presynaptic inputs to the LHb (Li et al., 2011; 
Shabel et al., 2012) or LHb inputs to the midbrain alone produces aversion. Since  
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LHb projections are phylogenetically well-conserved (Stephenson-Jones et al., 
2012), neurotransmission in this pathway is likely essential for survival by promoting 
learning and subsequent behavior to avoid stimuli associated with negative 
consequence. 
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FIGURES 
Figure 2.1. The LHb sends a functional glutamatergic projection to the RMTg. 
(A) Expression of ChR2-eYFP (green) following injection of the viral construct into 
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the LHb.  Neurons were counter-stained using a red fluorescent Nissl stain. D, 
Dorsal; V, Ventral; M, Medial; L, Lateral. (B,C) Activation of ChR2 expressed in LHb 
cell bodies in brain slices resulted in sustained high frequency activation during the 
500 ms stimulation (n=7 cells).  (D) Sagittal confocal image showing expression of 
ChR2-eYFP in the LHb-to-midbrain pathway via the fasciculus retroflexus fiber 
bundle following injection of the viral construct into the LHb.  Midbrain TH+ 
dopaminergic neurons are shown in blue.  A, Anterior; P, Posterior. (E) Horizontal 
confocal image showing the distribution of LHb terminals in the midbrain.  (F) 
Confocal compressed z-stack showing that ChR2-eYFP is expressed in LHb 
projection fibers in the RMTg after virus injection into the LHb.   (G) Postsynaptic 
optically-evoked EPSCs recorded from RMTg neurons were significantly attenuated 
following bath application of 10µM DNQX (t6 = 3.94, p = 0.07, n = 4 cells).  (H) LHb 
efferents to the RMTg were stimulated at 60 Hz for all behavioral tasks.  Optically-
evoked EPSCs at this frequency for 500 ms show a significant reduction in 
amplitude across the pulse train stimulation (F2,29 = 60.21, p < 0.001, n = 5 cells).  All 
error bars for all figures correspond to the s.e.m. *indicates p < 0.05 and ** indicates 
p < 0.01 for all figures.  
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Figure 2.2: Acute unpredictable foot shock exposure enhances LHb-to-RMTg 
glutamate release.  (A) Representative mEPSC traces recorded from neurons from 
mice immediately following either 0 or 19 unpredictable foot shocks.  (B) 
Representative cumulative mEPSC inter-event interval probability plot.  Inset: 
Average mEPSC frequent was significantly increased in neurons from shock 
exposed mice (t13 = 2.88, p = 0.01) (C) Representative cumulative mEPSC 
amplitude probability plot.  Inset: Average mEPSC amplitude was not altered in 
RMTg neurons from shock-exposed mice (t13= 0.12, p = 0.19).  (D) Representative 
optically evoked paired-pulse ratios from LHb efferents onto RMTg neurons. (E) 
Average paired-pulse ratios showing that paired-pulse ratios at LHb-to-RMTg 
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synapses were significantly depressed from mice that received foot shocks (t14 = 
3.56, p = 0.003, n = 8 cells/group).  (F) Representative optically evoked 
AMPA/NMDA ratios at LHb-to-RMTg synapses following 0 or 19 foot shocks.  (G) 
Optically evoked AMPA/NMDA ratios were not significantly different between the 
groups t14 = 0.36, p = 0.86, n = 8 cells/group).  
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Figure 2.3: Activation of LHb inputs to the RMTg produces active and 
conditioned behavioral avoidance.  (A) Real-time place preference location plots 
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from two representative mice showing the animal’s position over the course of the 
20-min session. (B) ChR2-eYFP-expressing mice spent significantly less time on the 
stimulated-paired side (t10 = 7.90, p < 0.0001, n = 6 mice/group for real-time place 
preference. (C) ChR2-eYFP-expressign mice made significantly more escape 
attempts during the real-time place preference session than eYFP-expressing mice 
(t10 = 2.82, p = 0.018).  (D) Total distance (cm) during the real time place preference 
experiment across the entire arena was not significantly different between groups 
(t10 = 0.37, p = 0.72). (E) Average velocity across the entire 20-min session across 
the entire arena was not significantly different between groups (t10 = 0.34, p = 0.74, n 
= 6 mice per group).  (F) ChR2-eYFP-expressing mice spent significantly less time in 
the stimulation=paired chamber compared with the nonstimulation-paired chamber 
24 h after the last stimulation conditioning session (t7 = 3.54, p = 0.01). eYFP 
expressing mice did not show a preference (t7 = 0.57, p = 0.58). (G) ChR2-eYFP-
expressing mice spent significantly less time in the stimulation=paired chamber 
compared with the nonstimulation-paired chamber 7 d after the last stimulation 
conditioning session (t7 = 3.24, p = 0.01). eYFP expressing mice did not show a 
preference (t7 = 0.17, p = 0.86). n = 8 mice per group for conditioned place 
preference. Error bars represent s.e.m. 
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Figure 2.4: Activation of LHb inputs to the RMTg promotes negative 
reinforcement. (A) Behavioral schematic for the 1-hr negative reinforcement 
session.  (B) Active and inactive nose-poke responses from ChR2-eYFP-expressing 
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mice over the first 3 days of training.  There was a significant interaction between 
active lever presses and days (F2,10 = 3.86, p = 0.03).  (C) Active and inactive nose-
poke responses from eYFP-expressing mice over the first 3 days of training.  There 
was no significant interaction between active lever presses and days (F2,10 = 0.84, p 
= 0.44) (D) Example cumulative records of active nose-pokes made by a ChR2-
eYFP and eYFP-expressing mouse to terminate LHb-to-RMTg optical activation.  (E) 
Average number of active nose-pokes from one behavioral session in following 
training (> 4 days; t10 = 20.52, p < 0.0001). There was no difference in inactive nose 
pokes between the two groups (t10 = 0.29, p = 0.78). n = 6 mice per group.  Error 
bars represent s.e.m. 
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Figure 2.5: Activation of LHb inputs to the RMTg disrupts positive 
reinforcement (A) Behavioral schematic for the 1-hr positive reinforcement session.  
(B) Example cumulative records of active nose pokes made by a ChR2-eYFP-
expressing mouse and an eYFP-expressing mouse when optical stimulation was 
paired with the nose poke to receive a sucrose reward.  (C) Average number of 
active and inactive nose pokes during positive reinforcement (t14 = 4.01, p < 0.01).  
There was no difference in inactive nose pokes between the two groups (t14 = 1.22, 
p = 0.24) (D) The inter nose-poke interval (time between each nose-poke averaged 
across the session) was significantly higher in ChR2-eYFP-expressing mice (t3577 = 
10.8, p < 0.001).  (E) Example histograms of licks time-locked to active nose-pokes 
for ChR2-eYFP-expressing mouse (top) and ChR2-eYFP-expressing mouse 
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(bottom). (F) Cumulative probability of the latency to lick following stimulation for 
ChR2-eYFP and eYFP—expressing mice.  (G) Average latency to lick following 
stimulation for ChR2-eYFP and eYFP-expressing mice (t2032 = 2.5, p = 0.01) n = 8 
mice per group.  Error bars represent s.e.m. 
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CHAPTER 3: A UNIQUE POPULATION OF VENTRAL TEGMENTAL AREA 
NEURONS INHIBITS THE LATERAL HABENULA TO PROMOTE REWARD3 
 
INTRODUCTION 
Dopaminergic neurons in the ventral tegmental area (VTA) are thought to 
encode reward prediction error—the difference between an expected reward and 
actual reward. Consistent with this, dopaminergic neurons are phasically excited by 
reward and the cues that predict them and are phasically inhibited by the omission of 
reward and aversive stimuli (Cohen et al., 2012; Matsumoto and Hikosaka, 2007; 
Pan and Hyland, 2005; Schultz et al., 1997; Tobler et al., 2005; Ungless et al., 
2004). Increased firing rate of dopaminergic neurons in response to salient stimuli 
causes phasic dopamine release in the nucleus accumbens (NAc), a signaling event 
thought to be critical for initiation of motivated behaviors (Day et al., 2007; Grace, 
1991; Oleson et al., 2012; Phillips et al., 2003b; Stuber et al., 2008). 
The lateral habenula (LHb) is a key neuroanatomical regulator of midbrain 
reward circuitry. Although dopaminergic neurons are excited by rewarding stimuli 
and inhibited by the omission of reward, neurons in the LHb display contrary 
responses: they are inhibited by cues that predict reward and excited by the 	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  3This chapter previously appeared as an article in the journal Neuron.  The original 
citation is as follows: Stamatakis, A.M., Jennings, J.H., Ung, R.L., Blair, G.A., 
Weinberg, R.J., Neve, R.L., Boyce, F., Mattis, J., Ramakrishnan, C., Deisseroth, K., 
and Stuber, G.D. (2013) A unique population of ventral tegmental area neurons 
inhibits the lateral habenula to promote reward. Neuron.  4. 1039-1053. 	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omission of reward (Matsumoto and Hikosaka, 2007). Importantly, in response to the 
omission of reward, excitation of the LHb neurons precedes the inhibition of 
dopaminergic neurons, suggesting that LHb neurons may modulate VTA 
dopaminergic neurons. Further supporting this claim, electrical stimulation of the 
LHb inhibits midbrain dopaminergic neurons (Christoph et al., 1986; Ji and Shepard, 
2007), whereas pharmacological inhibition of the LHb increases dopamine release in 
the striatum (Lecourtier et al., 2008). Collectively, these data suggest that LHb 
neurons encode negative reward prediction errors and may negatively modulate 
midbrain dopaminergic neurons in response to aversive events. 
The LHb sends a functional glutamatergic projection to the rostromedial 
tegmental nucleus (RMTg, also referred to as the tail of the VTA), a population of 
GABAergic neurons located posterior to the VTA (Brinschwitz et al., 2010; Jhou et 
al., 2009b; Stamatakis and Stuber, 2012). In vivo activation of VTA-projecting LHb 
neurons (Lammel et al., 2012), or LHb glutamatergic terminals in the RMTg, 
produces aversion and promotes motivated behavior to avoid further activation of 
the LHb-to-RMTg pathway (Stamatakis and Stuber, 2012), demonstrating a causal 
role for this pathway in controlling aversive behavior. Because GABAergic RMTg 
neurons inhibit midbrain dopaminergic neurons (Matsui and Williams, 2011), the 
RMTg is likely the intermediary structure through which the LHb inhibits midbrain 
dopaminergic neurons. 
Although the LHb-to-midbrain circuit has been dissected both functionally and 
behaviorally, less is known about the importance of the various LHb afferents. Inputs 
to the LHb arise from forebrain regions including the lateral hypothalamus, 
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entopenduncular nucleus (EN), and prefrontal cortex (Kim and Lee, 2012; Poller et 
al., 2013; Shabel et al., 2012; Warden et al., 2012).  A recent study suggests that 
aversive signaling by the LHb is mediated in part from the EN, as in vivo activation of 
these afferents in the LHb is aversive (Shabel et al., 2012).  Although the majority of 
LHb afferents arise from the forebrain, the LHb also receives a substantial projection 
from the VTA (Gruber et al., 2007; Phillipson and Griffith, 1980; Skagerberg et al., 
1984), with an estimated 30%–50% of LHb-projecting VTA neurons being 
dopaminergic (Gruber et al., 2007; Skagerberg et al., 1984). Electrical stimulation of 
the midbrain decreases the firing rate of LHb neurons (Shen et al., 2012), but the 
functional and behavioral significance of synaptic inputs to the LHb arising from VTA 
dopaminergic neurons remains unknown. Here, we demonstrate that selective 
activation of this projection inhibits LHb neurons by the actions of synaptically 
released GABA, which disinhibits VTA dopaminergic neurons to promote reward-
related behavior. 
 
METHODS 
Subjects and Stereotactic Surgery 
Adult (25–30 g) mice were group housed until surgery and maintained on a 
reverse 12 hr light cycle (lights off at 8:00) with ad libitum access to food and water. 
Mice were anesthetized with ketamine (150 mg/kg of body weight) and xylazine 
(50 mg/kg) and placed in a stereotactic frame (Kopf Instruments). For all slice 
electrophysiology and fast-scan cyclic voltammetry experiments, except for the 
retrobeads experiments, male and female TH-IRES-Cre backcrossed to C57BL/6J 
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were bilaterally microinjected with 0.5 µl of purified and concentrated adeno-
associated virus serotype 5 (AAV5; ∼1012 infections units per ml, packaged and 
titered by the UNC Vector Core Facility) into the VTA.  Each VTA was injected with 
an AAV5 coding Cre-inducible ChR2 under control of the EF1α promoter to 
transduce VTA dopaminergic neurons (THVTA::ChR2). For the retrobead slice 
electrophysiology and PCR retrobead experiments, male and female TH-IRES-GFP 
mice received quadruple injections of 0.3 µl of red retrobeads (Lumafluor) into either 
the NAc or LHb. For the retrobead mapping and quantification experiments, male 
C57BL/6J mice (Jackson Laboratory) received quadruple injections with 0.3 µl of red 
retrobeads into the NAc. In the same surgery, the mice also received quadruple 
injections of 0.3 µl with green retrobeads (Lumafluor) into the LHb. For tracing 
experiments, TH-IRES-Cre mice were bilaterally injected with 0.5 µl of HSV-EF1α-
LS1L-flp into the LHb or NAc and bilaterally injected with 0.5 µl of AAV5-EF1α-
fdhChR2(H134R)-eYFP into the VTA.  For behavioral experiments, male TH-IRES-
Cre positive (THVTA-LHb::ChR2) and negative (THVTA-LHb::Control) littermates were 
bilaterally injected with Cre-inducible ChR2 and also implanted with bilateral chronic 
fibers directed above the LHb. For the LHb microinjection experiments, a 26G steel 
tube cannula (McMasters-Carr) that terminated 0.5 mm above the tip of the optical 
fiber was epoxied to an optical fiber and bilaterally aimed at the LHb. Retrobead 
experiments were performed 7–21 days after surgery. All other experiments were 
performed 6–8 weeks after surgery.  All procedures were conducted in accordance 
with the Guide for the Care and Use of Laboratory Animals, as adopted by the US 
National Institutes of Health, and with approval of the UNC Institutional Animal Care 
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and Use Committees. 
Stereotactic coordinates 
VTA coordinates (in mm from bregma): −3.1 anterior/posterior, ±0.4 
medial/lateral, −5.0 dorsal/ventral.  NAc coordinates (quadruple injections) at four 
different sites (in mm from bregma): +1.0 and 1.5 anterior/posterior, ±1.0 
medial/lateral, −4.4 dorsal/ventral.  LHb coordinates (quadruple injections) at four 
different sites (in mm from bregma): -1.3 and -1.9 anterior/posterior, ±0.44 
medial/lateral, -3.44 dorsal/ventral.  LHb fiber coordinates (in mm from bregma at 
15º): -1.7 anterior/posterior, ±1.25 medial/lateral, -3.24 dorsal/ventral. 
HSV vector construction 
To optimize Adult the transcriptional cassette in the ST HSV vector backbone, 
thereby creating LT HSV, the entire CMV-transgene-SV40 polyadenylation (pA) 
signal cassette in ST HSV was replaced with an optimized cassette that had been 
previously assembled.  The ST HSV and LT HSV have different promoters.  The 
hCMV-IE1 promoter in the ST HSV was derived from pEGFP-C1 (Clontech), 
whereas it has been replaced with the EF1α promoter in LT HSV.  The LT HSV 
vector also contains base pairs 1064-1750 of the Woodchuck Hepatitis Virus post-
transcriptional response element (WPRE; (Donello et al., 1998)) which contributes to 
stabilization of expression.  The promoter is flanked on the 5’ side by the HSV oriS 
and IE4/5 promoter, which are followed by a SV40 A signal.  The 3’ pA signal in ST 
HSV is the SV40 late pA signal, and was derived from pCI (Promega), whereas the 
3’ pA signal in LT HSV is the SV40 early pA signal.   
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Histology, immunohistochemistry, and confocal microscopy 
Mice were anesthetized with pentobarbital, and transcardially perfused with 
PBS followed by 4% (w/v) paraformaldehyde in PBS.  Brains were then removed 
and submerged in 4% paraformaldehyde for 24 hr and transferred to 30% sucrose in 
ddH2O for 48 hr.  40 mm brain sections were obtained and subjected to 
immunohistochemical staining for neuronal cell bodies (NeuroTrace Invitrogen; 640-
nm excitation/660-nm emission or 435-nm excitation/455-nm emission), and/or 
tyrosine hydroxylase (Pel Freeze; made in sheep, 1:500).  Brain sections were 
mounted, and z-stack and tiled images were captured on a Zeiss LSM 710 confocal 
microscope using a 20x, 40x, or 63x objective and analyzed using ZEN 2009 and 
ImageJ software.  To quantify fluorescence intensity, images were acquired using 
identical pinhole, gain, and laser settings for all brain regions.  Intensity was then 
quantified using a scale from 0-255 in Image J to determine mean intensity.  For co-
localization analysis, Coloc2 software (Fiji) was used.  To determine optical fiber 
placement, tissue was imaged at 10X and 20X on an upright conventional 
fluorescent microscope.  
Electron Microscopy 
THVTA-LHb::ChR2 mice were deeply anesthetized and intracardially perfused 
with PBS followed by a mixture of 4% paraformaldehyde and 1% glutaraldehyde in 
0.1 M phosphate buffer, pH 7.2 (PB). Brains were removed and postfixed overnight 
in the same fixative.  50 µm-thick coronal sections throughout the LHb were cut on a 
Vibratome and collected in PB. Epifluorescence screening of wet sections was 
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performed to confirm appropriate fluorescent label of fibers in LHb. Sections were 
incubated at room temperature on a shaker in 1% hydrogen peroxide for 10 min (to 
block endogenous peroxidases), 30 min in 10% normal donkey serum (to block 
nonspecific antibody binding), and then overnight in chicken anti-GFP IgG (1:5,000). 
The next day sections were rinsed, blocked in 2% normal donkey serum, and treated 
with biotinylated secondary antibody against chicken IgG (Jackson 
ImmunoResearch, 1:200). After one hour incubation, sections were rinsed and 
incubated in ExtrAvidin (Sigma, 1:5,000) followed by standard diaminobenzidine 
histochemistry (for pre-embedding immunoperoxidase), or Nanogold-conjugated 
streptavidin (Nanoprobes, 1:100) followed by silver enhancement with IntenSE M 
(Amersham) for visualization of pre-embedding immunogold.  Immunoprocessed 
sections were incubated 1 h in osmium tetroxide solution (0.1-0.5% in PB), rinsed in 
maleate buffer (0.1 M, pH 6.0), then 1 h in uranyl acetate (1% in maleate). Sections 
were dehydrated through graded ethanol, infiltrated in Spurr's resin, and sandwiched 
between two sheets of ACLAR plastic.  They were then flat embedded between 
glass slides and heat-polymerized at 60° C for 48 hours.  After polymerization, bits of 
tissue were cut from LHb and glued to plastic blocks.  Thin sections (~70 nm) were 
cut with a diamond knife and collected on 300 mesh nickel grids (Ted Pella) for 
further processing. For single-label analysis, sections were post-stained with uranyl 
acetate and Sato's lead; for double-label study, sections first processed for 
postembedding immunogold labeling for GABA, as previously described (Phend et 
al., 1992), before post-staining. Grids were examined in a Tecnai F12 transmission 
EM (FEI); images were collected with a Gatan 12-bit cooled CCD. Images were 
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cropped and contrast adjusted using Adobe Photoshop. 
Slice Preparation for Single-Cell RT-PCR, Fast-Scan Cyclic Voltammetry, and 
Patch-Clamp Electrophysiology 
Mice were anesthetized with pentobarbital and perfused transcardially with 
modified artificial cerebrospinal fluid. Brains were then rapidly removed and placed 
in the same solution that was used for perfusion at ∼0°C. For the PCR experiments, 
horizontal slices containing the VTA (200 µm) were cut on a Vibratome (VT-1200, 
Leica Microsystems). For fast-scan cyclic voltammetry, coronal slices containing 
either the NAc (250 µm), (BNST 250 µm), or LHb (250 µm) were obtained. For 
patch-clamp electrophysiology, coronal slices containing the LHb (200 µm), or 
horizontal slices containing the VTA (200 µm) were obtained. Following slicing, brain 
slices were placed in a holding chamber and were allowed to recover for at least 
30 min before being placed in the recording chamber and superfused with 
bicarbonate-buffered solution saturated with 95% O2 and 5% CO2. 
Patch-clamp Electrophysiology 
Modified artificial cerebral spinal fluid contained (in mM): 225 sucrose, 119 
NaCl, 1.0 NaH2PO4, 4.9 MgCl2, 0.1 CaCl2, 26.2 NaHCo3, 1.25 glucose.  
Bicarbonate-buffered solution contained (in mM): 119 NaCl, 2.5 KCl, 1.0 NaH2PO4, 
1.3 MgCl2, 2.5 CaCl2, 26.2 NaHCO3, and 11 glucose (at 32-34°C).  Potassium 
chloride internal solution contained (in mM): 135 KCl, 0.5 EGTA, 10 HEPES, 1.5 
MgCl2, in RNAse- and DNAse-free water (Millipore).  Methanesulfonic acid 
contained (in mM):  117 Cs methanesulfonic acid, 20 HEPES, 0.4 EGTA, 2.8 NaCl, 
5 TEA, 2 ATP, 0.2 GTP. Cesium chloride internal solution contained (in mM): 130 
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CsCl, 1 EGTA, 10 HEPES, 2 ATP, 0.2 GTP.  Potassium gluconate internal solution 
contained (in mM): 130 K-gluconate, 10KCl, 10 HEPES, 10 EGTA, 2 MgCl2, 2ATP, 
0.2 GTP.  pH = 7.35, 270-285 mOsm for all internal solutions.  For voltage-clamp 
recordings, patch electrodes (3-5 MW) were back-filled with either a cesium 
methanesulfonic acid or cesium chloride internal solution.  Cells were visualized 
using infrared differential contrast and fluorescence microscopy. For current-clamp 
and cell-attached recordings, patch electrodes (3-5 MW for current-clamp, 2-4 MW 
for cell-attached) were back-filled with a potassium gluconate internal solution.  
Whole-cell voltage-clamp, current-clamp, and cell-attached recordings of LHb or 
VTA dopaminergic neurons were made using an Axopatch 700B amplifier (Molecular 
Devices).  For all optical stimulations, blue light (1 mW, 473 nm) was delivered 
through a 40X objective via a LED.  Series resistance (15-25 MW) and/or input 
resistance were monitored online with a 5-mV hyperpolarizing step delivered 
between stimulation sweeps.  All data were filtered at 2kHz, digitized at 5-10kHz, 
and collected using pClamp10 software (Molecular Devices).  For the autoreceptor 
experiment, following 5-10 min of baseline recording, 3 µm of the D2 agonist 
quinpirole was bath-applied for 5 min.  For IPSCs, following 5-10 min of baseline 
recording, 1 mM of the K+ channel blocker 4AP, and 1 µM of the Na+ channel 
blocker TTX was bath-applied for 10 min, followed by a 10 min bath application of 
10 µM of the GABAA receptor antagonist, SR-95531 (gabazine). IPSC and EPSC 
amplitudes were calculated by measuring the peak current from the average 
response from 6 sweeps during baseline and during each drug application. Cells that 
showed a > 20% change in the holding current or access resistance were excluded 
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from analysis.  To inhibit vesicular monoamine transporters THVTA::ChR2 mice were 
injected intraperitoneally with the irreversible Vmat2 inhibitor reserpine (5 mg/kg) 24 
h prior to slicing (Tritsch et al., 2012).  Brain slices from these mice were prepared 
as described above, but were incubated in aCSF containing 1 µM reserpine.  For the 
cell-attached recordings, following 5-10 min baseline recording, 10 µM of the D1 
antagonist SCH23390 and 10 µM of the D2 antagonist raclopride were washed on 
for 10 min, followed by a 10 min bath application of 10 µM of the GABAA receptor 
antagonist, SR-95531 (gabazine).  For the retrobeads experiments, whole-cell 
voltage clamp and cell-attached recordings were made from GFP+ neurons 
containing red retrobeads in the VTA. Ih current was measured by voltage-clamping 
the cell and stepping from −70 mV to −105 mV in 5 mV steps. For voltage-clamp 
recordings in LHb neurons, membrane potentials were maintained at −70 mV, and 
light pulses were delivered every 20 s to evoke neuronal firing. For cell-attached 
recordings, a 20-Hz optical stimulation was delivered for 1 s every 20 s for 20 
sweeps. Firing rate was averaged across all 20 sweeps. 
RT-PCR 
Autoclaved patch electrodes (2.0–2.5 MΩ) were backfilled with ∼3–5 µl of a 
potassium chloride internal solution. Two microliters of RNase inhibitor (ANTI-
RNase, Life Technologies) were added per 1 ml of the potassium chloride internal 
solution. Holding current was measured for no more than 3 min to minimize potential 
mRNA degradation. The cytoplasm was then aspirated by applying negative 
pressure and the integrity of the seal was monitored during aspiration to prevent 
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extracellular contamination. Cells that showed more than a 100-pA change in 
holding current during aspiration were discarded. Immediately following aspiration, 
the pipette was removed from the tissue and the tip was broken into an RNase-free 
PCR tube. The solution inside the pipette was then injected into the RNase-free tube 
using positive pressure. Between each cell recording, the silver wire located inside 
the recording pipette was wiped thoroughly with 70% alcohol to minimize cross 
sample contamination. Finally, to control for pipette contamination, after each five 
consecutive recordings, a recording pipette was lowered into the tissue with positive 
pressure, but without aspiration (tissue-stick control) and was then processed for 
quantitative PCR.  
Single-cell gene expression profiling 
Extracted intracellular samples were profiled using the Single Cell-to-Ct Kit 
(Life Technologies).  Briefly, intracellular contents were prepared individually in lysis 
solution containing DNase.  The volume of lysis and DNase solution was reduced 
from the normal protocol to compensate for the added volume of internal solution 
from each sample (approximately 3-5 µL).  Reverse transcription of RNA to 
complementary DNA (cDNA) was then performed, followed by a multiplexed 
preamplification of all target genes using TaqMan Gene Expression Assays (Life 
Technologies).  The assays used to detect the target genes in the VTA were the 
recommended exon-spanning assays for Slc17a6 (vesicular glutamate transporter-2, 
Vglut2), Slc32a1 (vesicular GABA transporter, Vgat), GAD1/GAD2 (glutamate 
decarboxylase 1 and 2), Slc18a2 (vesicular monoamine transporter-2, Vmat2), 
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DRD2, (dopamine receptor D2), DAT1 (dopamine transporter), TH (tyrosine 
hydroxylase), and Rn18s (Control).  The house-keeping gene, Rn18s, is highly 
abundant in all cells, and was thus not preamplified in order to avoid a reduction of 
amplification of other cDNAs in the multiplexed sample.  Next, qPCR was performed 
to obtain the Ct values of each target gene by using a StepOnePlus qPCR 
instrument (Life Technologies) using recommended amplification parameters for 
TaqMan based probes.  Technical replicates from each individual biological sample 
were performed as well as those from tissue-stick control on the same 96-well plate.  
Thus, each 96 well plate contained 5 consecutively recorded cells and their 1 
subsequent tissue-stick control sample.   
Single-cell gene analysis 
qPCR data obtained from a given cell were not included for analysis if their 
qPCR amplification curves were not consistent across technical replicates or if they 
did not display a predicted sigmoidal amplification curve.  Additionally, tissue-stick 
controls did not display any expression of the profiled target genes following qPCR. 
Gene expression for each neuron was normalized to the sample’s Rn18s expression 
in order to account for the volume of each collected sample (ΔCt = Ctgene – CtRn18s).  
Gene expression for each neuron was then normalized and calculated as the 
difference between normalized gene expression of each gene and normalized 
average expression of that gene in THVTA-NAc neurons (ΔΔCt = ΔCt – Avg. ΔCt,VTA-
NAc).  These fold expression values for each gene were log transformed (Normalized 
gene amount relative to THVTA-NAc = 2-DDCt; (Livak and Schmittgen, 2001)) and 
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analyzed with a non-parametric t test (Mann-Whitney). Only data from TH-GFP 
neurons that expressed TH were included in the analysis.   
Fast-Scan Cyclic Voltammetry 
T-650 carbon fiber microelectrodes (100–200 µm in length) were used for 
detection of dopamine in brain slices. Electrodes were placed in the NAc core, 
dorsal lateral BNST, or LHb of THVTA::ChR2 brain slices. Every 100 ms, the potential 
applied to the electrode was ramped from −0.4 V to +1.3 V to −0.4 V versus a 
Ag/AgCl reference wire at a rate of 400 V/s. To increase the sensitivity to detect 
dopamine with fast-scan cyclic voltammetry, slices were prepared as described 
above, but were incubated in aCSF containing 1 µM GBR12909 and 10 µM 
raclopride for at least 1 hr before recording. Prior to recording, slices were 
preperfused with L-Dopa (10 µM) for 10 min. Additionally, the electrode was ramped 
from −0.6 to 1.4 V to −0.6 V versus a Ag/AgCl reference wire at a rate of 400 V/s.  
Electrochemical data were acquired using a custom-written software in LabVIEW 
and filtered at 1 kHz offline. 5-ms, 473-nm, 1-mW light pulses were delivered 
through a 40X objective via a high-powered LED (Thorlabs) to evoke dopamine 
release.  5 light pulses were delivered at 1, 2, 5, 10, and 20 Hz.  At 20 Hz, 1, 2, 4, 8, 
16, and 32 light pulses were delivered. Immediately after optical stimulation of the 
slice, background-subtracted cyclic voltammograms were generated, which were 
characteristic of dopamine (peak oxidation potential of 600-700 mV).   
In Vivo Circuit Activity Mapping of the THVTA-LHb Pathway 
For monitoring RMTg and VTA neural firing during optical stimulation of the 
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THVTA-LHb pathway, the recording electrode was lowered separately into the RMTg 
(−3.9 mm posterior to bregma, ±0.9 mm lateral to midline, and –3.6 mm ventral to 
skull surface) and VTA (−3.1 mm posterior to bregma, ±0.4 mm lateral to midline, 
and −5.0 mm ventral to skull surface) by a motorized micromanipulator (Scientifica). 
To optically stimulate THVTA-LHb terminals, an optical fiber coupled to a solid 
state laser (473 nm) was situated within a guide cannula and placed directly above 
the LHb at a 15° angle (−1.7 mm posterior to bregma, ±1.25 mm lateral to midline, 
and –3.24 mm ventral to skull surface). Train pulses of light (20 Hz) were delivered 
to the LHb every 3 s for 20 trials (each trial having 2 s prestimulation, 2 s stimulation, 
and 1 s poststimulation periods; Off, On, Off). To optically stimulate RMTg and VTA 
cell bodies, an optical fiber was fed through the side port of the electrode holder to 
terminate near the tip of the glass recording electrode. Recorded units were 
classified as light-responsive neurons if reliable light-evoked spikes were detected 
during the presentation of 2-ms light pulses (20 trials each). 
THVTA::ChR2 mice were anesthetized with choral hydrate (4% w/v. 480 mg/kg 
i.p.) and supplemental doses were provided as needed (4% w/v, 120 mg/kg i.p.) 
(Sigma).  A homeothermic heating blanket (Harvard Apparatus, Holliston, MA) was 
used to maintain body temperature at ~ 37°C and lidocaine (2%) was applied to the 
incision site (Akorn).  A reference electrode was fixed within brain tissue and 
extracellular neural activity was recorded using glass recording electrodes (5-10 MΩ: 
and filled with 0.5 M NaCl).  All recordings were amplified (Multiclamp 700B, 
Molecular Devices), bandpass filtered between 300 Hz and 16 kHz and sampled up 
to 40 kHz. Data acquisition and analysis was performed using pCLAMP software 
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(Molecular Devices) and placements of recording electrode tips within the RMTg and 
VTA were verified with histological examination of brain tissue following the 
experiments. 
Real-time place preference 
THVTA-LHb::ChR2 and THVTA-LHb::Control mice bilaterally implanted with optical 
fibers aimed at the LHb were placed in a custom-made behavioral arena (50 × 50 × 
25 cm black plexiglass) for 20 min. One counterbalanced side of the chamber was 
assigned as the stimulation side. At the start of the session, the mouse was placed 
in the non-stimulated side of the chamber.  Every time the mouse crossed to the 
stimulation side of the chamber, 20-Hz constant laser stimulation was delivered until 
the mouse crossed back into the non-stimulation side.  Percent time spent on the 
stimulation-paired and velocity was recorded via a CCD camera interfaced with 
Ethovision software (Noldus Information Technologies).   
 
Intra-LHb injection of antagonist and photostimulation during RTPP test 
THVTA-LHb::ChR2 mice bilaterally implanted with a 26-gauge cannula coupled 
to an optical fiber aimed above the LHb were placed in the place-preference 
chamber and were run in the RTPP task to achieve a baseline measurement.  24 hr 
following the baseline measurement, mice received intra-LHb bilateral 0.3 µL 
microinjections of vehicle (saline), a dopamine receptor antagonist cocktail (600 ng 
of SCH23390 to block D1 receptors and 100 ng raclopride to block D2 receptors in 
saline), or gabazine (5 ng in saline) counterbalanced across days.  The injector 
needles (33-gauge steel tube, McMasters-Carr) extended approximately 1 mm past 
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the cannula to ensure drug delivery 0.5 mm below the optical fiber.  All drugs were 
infused at a rate of 1.5 µL/min.  The injector remained in place for 2 min after 
infusion to ensure diffusion of drug into the LHb.  Immediately after the infusion 
procedure, mice were placed into the RTPP chamber.  Mice had at least 24 hours 
without manipulation between each LHb microinjection. 
Systemic injection of antagonist and photostimulation during the RTPP test 
7 days following the intra-LHb microinjections, THVTA-LHb::ChR2 mice were 
given i.p. injections of either vehicle (saline) or a dopamine receptor antagonist 
cocktail (0.04 mg/kg SCH23390 and 0.075 mg/kg raclopride). 20 min following the 
injection, mice were placed into the RTPP chamber.  Mice had at least 24 hr without 
manipulation between each injection.  
Optical self-stimulation 
THVTA-LHb::ChR2 and THVTA-LHb::Control mice bilaterally implanted with optical 
fibers aimed at the LHb were given daily, 1 hr access to operant chambers (Med 
Associates) interfaced with optogenetic stimulation equipment.  Mice were trained on 
a fixed-ratio 1 training schedule to nose-poke for optical stimulation of THVTA-
LHb::ChR2 fibers.  Each nose-poke in the active port resulted in a 3-s 20-Hz optical 
pulse train that was paired with a 3-s tone and houselight cue.   
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5-choice optical self-stimulation 
At least 24 hr following optical self-stimulation, THVTA-LHb::ChR2 and THVTA-
LHb::Control mice bilaterally implanted with optical fibers aimed at the LHb were given 
one, 1-hr session in an operant chamber containing 5 nose-poke ports. A nose-poke 
in each port would result in a 1-, 5-, 10-, 20-, or 40-Hz optical stimulation.  The 
pairing of the port with the frequency was counterbalanced between mice.    
 
RESULTS 
Optogenetic Targeting of VTA Dopaminergic Neurons and Innervation to the 
LHb 
To selectively target VTA dopaminergic neurons, we introduced a Cre-
inducible viral construct coding for channelrhodopsin-2 fused to an enhanced yellow 
fluorescent protein (ChR2-eYFP) bilaterally into the VTA of tyrosine hydroxylase 
(TH)-internal ribosome entry site-Cre (THVTA::ChR2) adult mice as previously 
described (Tsai et al., 2009).  
Three to four weeks following surgery, we observed robust ChR2-eYFP 
expression in the VTA (Figure 3.1 A,B).  To ensure the specificity of ChR2-eYFP for 
dopaminergic neurons, we quantified the number of VTA neurons that were TH-
positive (TH+) and eYFP-positive (eYFP+). We found that 62.4% ± 3.4% of VTA 
neurons were TH+, 48.6% ± 0.9% were eYFP+, and 99.2% ± 0.4% of the eYFP+ 
neurons were also labeled with TH (Figure 3.1 C), consistent with previous results 
(Tsai et al., 2009).  Six weeks following surgery, we observed eYFP expression that 
was largely restricted to the LHb relative to neighboring structures (Figure 3.1 D,E).  
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Fluorescence quantification analysis in brain slices containing the LHb revealed that 
axonal fibers originating from VTA dopaminergic neurons densely innervated the 
LHb, but only sparsely innervated surrounding structures, such as the medial 
habenula, thalamus, and hippocampus (Figure 3.1 F). 
 
LHb-Projecting VTA Dopaminergic Neurons Do Not Send Axon Collaterals to 
Other Reward-Related Brain Structures 
We next determined whether LHb-projecting VTA dopaminergic neurons 
(THVTA-LHb) collateralize and project to other brain regions. To accomplish this, we 
utilized an intersectional genetic approach to selectively label TH+ neurons in the 
VTA that project to the LHb. We bilaterally injected the LHb of TH-Cre mice with 
a retrogradely transducing herpes simplex virus (Chaudhury et al., 2013) encoding a 
Cre-inducible flippase recombinase (flp) under control the of an Ef1α promoter 
fragment (HSV-EF1α-LS1L-flp) (Figure 3.2 A; see METHODS for more detail) 
(Kuhlman and Huang, 2008). In the same surgery, we bilaterally injected a flp-
inducible ChR2-eYFP (AAV5-EF1α-fdhChR2(H134R)-eYFP; a construct designed 
with the same structure as the Cre-inducible viral construct coding for ChR2 (Tsai et 
al., 2009) into the VTA (Figure 3.2 B).  This resulted in the selective labeling of the 
somas and processes of VTA TH+ neurons that project to the LHb. If THVTA-LHb 
neurons collateralize to other target regions, we would expect to see eYFP+ fibers in 
these regions as well as the LHb. However, 6 weeks following this procedure, we 
observed eYFP+ fibers in the LHb, but not in other terminal regions of VTA 
dopaminergic neurons, such as the medial prefrontal cortex (mPFC), NAc (Figure 
3.2 B; n = 6 slices from n = 3 mice), basolateral amygdala (BLA), or bed nucleus of 
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the stria terminalis (BNST, data not shown), suggesting that THVTA-LHb neurons only 
project to the LHb and do not send collaterals to these other target structures. 
Additionally, in a separate group of TH-Cre mice, we bilaterally injected the HSV-
EF1α-LS1L-flp virus into the NAc and the AAV5-EF1α-fdhChR2(H134R)-eYFP virus 
into the VTA. In these mice, we observed eYFP+ fibers in the NAc, but not in the LHb 
(Figure 3.2 C; n = 6 slices from n = 3 mice). 
 
THVTA-LHb Neurons Are Distinct from THVTA-NAc Neurons 
To further confirm that THVTA-LHb neurons are anatomically distinct from NAc-
projecting VTA dopaminergic neurons (THVTA-NAc), and to provide an anatomical map 
of these discrete populations within the VTA, we performed retrograde tracing 
by injecting red fluorescent beads into the NAc and green fluorescent beads into the 
LHb of the same C57/BL6J wild-type mice (Figure 3.3 A). Three weeks following 
surgery, VTA sections were collected and immunostained for TH. We found that 
THVTA-LHb neurons were located in anterior and medial regions, congregating mainly 
in the interfasicular nucleus, whereas THVTA-NAc neurons were generally located 
more posterior and lateral (Figure 3.3 B). Additionally, we observed significantly 
more THVTA-NAc neurons than THVTA-LHb neurons throughout the VTA (Figure 3.3 B).  
Supporting our viral tracing data, we detected no TH+ neurons that expressed both 
red and green retrobeads in the VTA. Collectively, these data demonstrate that 
THVTA-LHb and THVTA-NAc neurons are completely separate neuronal populations. 
Because we found that THVTA-NAc and THVTA-LHb neurons are separate 
populations of neurons within the VTA, we investigated whether these two 
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populations display different electrophysiological characteristics. To accomplish this, 
we injected two groups of TH-GFP mice with red retrobeads either in the NAc or LHb 
and performed whole-cell recordings from GFP-positive neurons in VTA brain slices 
containing retrobeads (Figure 3.4 A).  Unlike THVTA-NAc neurons, THVTA-LHb neurons 
did not show a hyperpolarization-activated inward rectifying current (Ih), a traditional 
(although disputed) marker of midbrain dopaminergic neurons (Margolis et al., 2006; 
Mercuri et al., 1995) (Figure 3.4 B). The lack of Ih, together with increased 
membrane resistance (Figure 3.4 C), suggests that THVTA-LHb neurons may be more 
excitable than THVTA-NAc neurons. Supporting this observation, we found that THVTA-
LHb neurons show enhanced spontaneous activity compared to THVTA-NAc neurons 
(Figure 3.4 D, E).   
A pharmacological signature of midbrain dopaminergic neurons is their 
hyperpolarization in response to D2 autoreceptor activation (Beckstead et al., 2004). 
To determine whether THVTA-LHb neurons are sensitive to D2 autoreceptor activation, 
we performed cell-attached recordings from THVTA-LHb and THVTA-NAc neurons in the 
VTA.  In line with previous data, we observed a significant decrease in spontaneous 
firing following a D2 receptor agonist (3 µM quinpirole) bath application in THVTA-NAc 
neurons (Figure 3.4 D-F) (Beckstead et al., 2004; Lammel et al., 2008).  However, 
quinpirole did not significantly change the spontaneous firing rate of THVTA-LHb 
neurons (Figure 3.4 D,F), demonstrating that THVTA-LHb neurons lack functional 
somatodendritic D2 autoreceptors. 
Because THVTA-LHb and THVTA-NAc neurons are anatomically and 
electrophysiologically distinct, we quantified the gene expression profiles of these 
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two populations. To characterize the molecular phenotype of THVTA-LHb and THVTA-NAc 
neurons, we injected two groups of TH-GFP mice with red retrobeads either in the 
NAc or LHb and 7 days later extracted the intracellular contents from individual GFP-
positive neurons in VTA brain slices containing retrobeads (Figure 3.5 A).  The 
intracellular content was then processed by reverse transcription quantitative PCR 
assaying the following genes: vesicular glutamate transporter-2 (Vglut2), vesicular 
GABA transporter (Vgat), glutamate decarboxylase 1 and 2 (GAD1/GAD2), vesicular 
monoamine transporter-2 (Vmat2), dopamine receptor D2 (DRD2), dopamine 
transporter (DAT1), and tyrosine hydroxylase (TH). We found that both THVTA-LHb 
and THVTA-NAc neurons expressed all tested genes classically associated with 
dopamine synthesis, release, and uptake (Vmat2, DRD2, DAT1, and TH; Figure 3.5 
B). However, THVTA-LHb neurons expressed significantly lower amounts of Vmat2, 
DRD2, and DAT1 compared to THVTA-NAc neurons (Figure 3.5 C).  Importantly, none 
of these dopaminergic markers were detected in GFP-negative neurons (n = 7 
neurons). Taken together, these data suggest that THVTA-LHb neurons 
are anatomically, electrophysiologically, and genetically distinct from THVTA-NAc 
neurons. 
 
Characterization of Neurotransmitter Release from THVTA-LHb Fibers 
To characterize the dynamics of dopamine release from synaptic fibers that 
innervate the LHb, we performed fast-scan cyclic voltammetry in LHb brain slices 
obtained from THVTA::ChR2 mice. Carbon-fiber microelectrodes were placed in areas 
within the LHb that displayed the highest ChR2-eYFP expression to ensure the 
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voltammetry electrodes were near presynaptic fibers and synapses that could be 
optically stimulated. We observed no detectable optically evoked dopamine release 
within the LHb, even after sustained high-frequency optical stimulation (Figure 3.6 
A-C).  As positive controls, we recorded light-evoked dopamine release in NAc and 
BNST brain slices obtained from the same THVTA::ChR2 mouse. We observed 
robust light-evoked dopamine release that increased as a function of either 
frequency or pulse number in both the NAc and BNST (Figure 3.6 A-C), consistent 
with previous studies in the NAc and dorsal striatum of rats (Bass et al., 2013; Witten 
et al., 2011).  We were unable to detect dopamine release in the LHb even after 
altering the parameters of the voltammetry experiments to increase the sensitivity of 
dopamine detection (data not shown; see METHODS for additional details). 
Fluorescence quantification analysis of THVTA::ChR2 fibers in the NAc, BNST, and 
LHb revealed that although the NAc had significantly higher eYFP fluorescence, 
there was no difference in eYFP intensity between the LHb and BNST (Figure 3.6 
D,E).  These data suggest that the lack of detectable dopamine release in LHb brain 
slices is not likely due to weaker innervation, as we observed optically-evoked 
dopamine release in BNST slices that show comparable innervation. 
In the NAc and BNST, we also observed intense TH immunofluorescence and 
a high degree of colocalization between eYFP+ fibers and TH immunostaining 
(Figure 3.6 D,F) in brain slices obtained from THVTA::ChR2 mice. In contrast, the 
LHb from the same mice exhibited strong eYFP fluorescence, but almost no TH 
immunoreactivity (Figure 3.6 D,F).  Quantitative analysis confirmed that 
colocalization (as assessed by Pearson’s correlation coefficient) between eYFP and 
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TH was 0.52 ± 0.05 for NAc and 0.50 ± 0.04 for the BNST, but only 0.010 ± 0.004 for 
the LHb. Together, these data suggest that fibers arising from VTA TH+ neurons 
express little or no TH in the fibers that innervate the LHb. 
Because we did not observe dopamine release in the LHb, we sought to 
determine whether this projection might release other neurotransmitters in the LHb. 
In light of recent studies demonstrating that dopaminergic fibers can corelease 
glutamate and GABA in the striatum (Stuber et al., 2010; Tecuapetla et al., 2010; 
Tritsch et al., 2012), we asked whether fibers and synapses originating from THVTA 
neurons were capable of releasing either of these neurotransmitters in the LHb. 
Accordingly, we performed whole-cell voltage-clamped recordings from postsynaptic 
LHb neurons in brain slices obtained from THVTA::ChR2 mice. To ensure we were 
only recording monosynaptic currents from THVTA::ChR2 fibers, we added a Na+-
channel blocker (1 µM TTX) and a K+-channel blocker (1 mM 4-AP) to the bath as 
previously described (Cruikshank et al., 2010). Voltage-clamp recordings from LHb 
neurons revealed that light pulses that selectively stimulated THVTA::ChR2 fibers in 
the LHb (THVTA-LHb::ChR2), produced light-evoked currents that were blocked by 
10 µM of the GABAA receptor antagonist gabazine (Figure 3.7 A-C).  Of the neurons 
we recorded from in the LHb, 82% (45/55) received a direct monosynaptic inhibitory 
input from THVTA neurons. Dopaminergic terminals in the dorsal striatum release 
GABA that is dependent on Vmat2 activity (Tritsch et al., 2012).  However, we 
observed no changes in inhibitory currents in LHb slices from THVTA::ChR2 mice 
treated with the Vmat2 inhibitor reserpine, compared to untreated slices (Figure 3.7 
D).  This same reserpine protocol was sufficient to inhibit electrically-evoked 
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dopamine release in the NAc (data not shown), demonstrating that this treatment 
was capable of inhibiting Vmat2 and depleting evoked dopamine. These data 
demonstrate that THVTA-LHb neurons do not require Vmat2 function to release GABA 
in the LHb. Additionally, we observed a small (−7.2 ± 2.2 pA) excitatory current in 
some of the recorded neurons (5/10), consistent with a previous study 
demonstrating that Vglut2-expressing VTA neurons (some of which could be 
dopaminergic) innervate the LHb (Hnasko et al., 2012). 
To determine whether activating THVTA-LHb::ChR2 terminals would affect the 
spontaneous firing rate of postsynaptic LHb neurons, we performed cell-attached 
recordings from LHb neurons and found that the average spontaneous firing rate of 
these neurons was 8.0 ± 2.2 Hz. When we delivered a 1 s 20 Hz optical pulse-train 
to optically stimulate THVTA-LHb::ChR2 terminals, we observed that the firing rate of 
LHb neurons significantly decreased (Figure 3.7 E-G), demonstrating that the net 
effect of THVTA-LHb::ChR2 terminal stimulation was to suppress the firing of LHb 
neurons. To determine whether this suppression of firing was due to GABA or 
dopamine release, we added a D1/D2 receptor antagonist cocktail (10 µM 
SCH23390 and 10 µM raclopride) to the bath, followed by a GABAA receptor 
antagonist (10 µM gabazine). The D1/D2 receptor antagonist did not modify the 
decrease in firing in response to optical stimulation, but the GABAA receptor 
antagonist blocked this decrease (Figure 3.7 G), leading us to conclude that the 
inhibition of spontaneous firing following activation of THVTA-LHb::ChR2 terminals is 
due to activation of GABAA receptors. 
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We performed electron microscopy to provide anatomical support for the 
electrophysiological findings. Accordingly, we collected images of THVTA-LHb::ChR2 
synapses (as defined by electron-dense DAB reaction product or silver-enhanced 
nanogold after pre-embedding immunostaining for eYFP). Postembedding 
immunogold staining performed on this material showed that many of these 
presynaptic terminals contained high levels of GABA (Figure 3.7 H).  In some cases 
we also saw terminals containing little or no GABA that made asymmetric synaptic 
contacts (Figure 3.8 A); these were likely to be glutamatergic. Collectively, these 
congruous findings demonstrate that THVTA-LHb::ChR2 terminals do not release 
detectable amounts of dopamine in the LHb in an impulse-dependent fashion. 
Instead, THVTA-LHb::ChR2 projections contain and release GABA, which functions to 
suppress the activity of postsynaptic LHb neurons. 
 
The Functional Significance of the THVTA-LHb Circuit in Regulating Midbrain 
Activity 
 
Because the inhibitory THVTA-LHb pathway suppresses the activity of 
postsynaptic LHb neurons (Figure 3.7 E-G), we next addressed whether activation 
of this inhibitory circuit has downstream effects on midbrain activity in vivo. Given 
that the LHb sends a strong glutamatergic projection to the RMTg (Stamatakis and 
Stuber, 2012), we assessed the functional consequences of THVTA-LHb activation on 
RMTg neuronal activity by recording extracellularly from RMTg neurons in 
anesthetized mice while stimulating THVTA-LHb terminals (Figure 3.9 A).  Optical 
stimulation of the THVTA-LHb pathway suppressed the spontaneous firing of RMTg 
neurons (Figure 3.9 B,C).  Further, these recorded RMTg units did not respond to 
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optical stimulation within the RMTg (Figure 3.9 D-G), confirming that the recorded 
neurons did not express ChR2-eYFP. In agreement with this, we observed minimal 
ChR2-eYFP and TH+ immunolabeling in RMTg brain slices (Figure 3.9 D).  
Therefore, we considered these neurons to be TH-negative neurons, consistent with 
previous data (Barrot et al., 2012). 
Because RMTg neurons directly inhibit VTA dopaminergic (THVTA) neurons 
(Matsui and Williams, 2011), we next determined if optical stimulation of THVTA-LHb 
terminals would enhance THVTA neuronal activity via disinhibition. First, to optically 
classify recorded units as THVTA neurons, we recorded the firing responses of VTA 
neurons to the delivery of 2 ms light pulses within the VTA (Figure 3.10 A,B).  
Optically identified THVTA neurons displayed time-locked activation to VTA optical 
stimulation (Figure 3.10 B,C).  
Following identification of THVTA neurons, we determined whether optical 
stimulation of the THVTA-LHb inhibitory pathway (by delivering 473 nm light directly into 
the LHb) could alter the spontaneous activity of THVTA neurons. Optical stimulation of 
THVTA-LHb terminals led to enhanced spontaneous activity in optically identified THVTA 
neurons (Figure 3.10 D,E).  Importantly, we determined that these light-evoked 
responses were unlikely to arise from antidromic activation of THVTA-LHb terminals, as 
THVTA-LHb initiated spikes had significantly longer spike latencies and greater spike 
jitter compared to the light-evoked spikes of THVTA neurons with direct optical 
stimulation in the VTA (Figure 3.10 F).  Furthermore, THVTA neurons did not respond 
reliably to 20 Hz optical stimulation of THVTA-LHb terminals (Figure 3.10 G).  
Collectively, these data suggest that the increases in firing of THVTA neurons initiated 
	   85	  
by THVTA-LHb terminal activation are mediated through synaptic transmission within a 
polysynaptic circuit. Taken together, these circuit-activity mapping experiments 
reveal the functional significance of the inhibitory THVTA-LHb pathway in regulating 
midbrain activity. 
 
Optogenetic Activation of the THVTA-LHb Pathway Produces Reward-Related 
Behavioral Phenotypes that Require GABAA Signaling 
In vivo, pharmacological inhibition of the LHb increases dopamine in forebrain 
regions such as the striatum (Lecourtier et al., 2008). Likewise, we observed that 
in vivo activation of the THVTA-LHb pathway increased the firing rate of midbrain 
dopaminergic neurons (Figure 3.10).  Therefore, we hypothesized that 
in vivo activation of the THVTA-LHb::ChR2 pathway would result in a reward-related 
phenotype. To test this hypothesis, we implanted bilateral optical fibers (Sparta et 
al., 2012) aimed directly above the LHb in THVTA-LHb::ChR2 mice and determined the 
behavioral ramifications of selectively activating the THVTA-LHb::ChR2 pathway. Using 
a real-time place preference assay, as previously described (Stamatakis and Stuber, 
2012), THVTA-LHb::ChR2 mice exhibited a significant preference for the side of the 
chamber that was paired with optical stimulation. In contrast, littermate controls 
(THVTA-LHb::Control) displayed no preference, demonstrating that activation of the 
THVTA-LHb::ChR2 pathway produces reward-related behaviors (Figure 3.11 A-C).  
This preference was dependent on GABAA signaling within the LHb, as intra-LHb 
microinjections of a GABAA receptor antagonist (gabazine) through guide cannulas 
interfaced with the optical fibers (Jennings et al., 2013a) blocked the preference for 
the stimulation-paired side (Figure 3.11 D).  Following intra-LHb GABAA agonist 
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(gabazine) we observed no significant difference in velocity compared to vehicle (t16 
= 0.4, p = 0.72).  In contrast, intra-LHb microinjection of a dopamine receptor 
antagonist (D1 and D2) cocktail did not block the rewarding phenotype (Figure 3.11 
D), whereas a systemic injection of the dopamine antagonist cocktail did disrupt the 
preference (Figure 3.11 E).  Velocity was significantly decreased following intra-LHb 
dopamine antagonist (D1/D2) compared to vehicle (t14 = 2.3, p = 0.04), however 
velocity was not significantly different following systemic dopamine antagonist 
compared to THVTA-LHb::Control mice (t13 = 0.77, p = 0.45).  These data suggest that 
the observed reward-related phenotype induced by optical stimulation of the THVTA-
LHb::ChR2 pathway does not depend on dopamine signaling within the LHb, but 
rather on downstream dopamine signaling in brain regions such as the NAc.  Finally, 
to determine if activation of the THVTA-LHb::ChR2 pathway is reinforcing, we trained 
mice to nose-poke for optical stimulation of the THVTA-LHb::ChR2 pathway (Figure 
3.11 F,G).  THVTA-LHb::ChR2 mice made significantly more nose-pokes to receive 
optical stimulation than THVTA-LHb::control mice (Figure 3.11 H). 
Taken together, these data demonstrate that although activation of THVTA-
LHb::ChR2 terminals does not result in detectable dopamine release in the LHb, 
selective activation of this pathway promotes reward-related behavior by 
suppressing LHb activity through the release of GABA, leading to disinhibition of 
VTA dopaminergic neurons. 
 
DISCUSSION 
Aberrant mesolimbic and mesocortical dopaminergic signaling has been 
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implicated in a range of neuropsychiatric diseases, including schizophrenia, 
addiction, and depression (Chaudhury et al., 2013; Knable and Weinberger, 1997; 
Lüscher and Malenka, 2011; Phillips et al., 2003b; Tye et al., 2013), motivating 
extensive studies of VTA dopaminergic projections to the striatum and prefrontal 
cortex. In contrast, little is known about the VTA’s projection to the LHb. Using 
optogenetics in combination with electrophysiology, genetically targeted neuronal 
tracing techniques, and behavior, we investigated the functional and behavioral 
significance of this mesohabenular pathway. 
Previous studies have demonstrated that separate populations of VTA 
dopaminergic neurons project to nonoverlapping target structures such as the NAc, 
BLA, and mPFC (Ford et al., 2006; Lammel et al., 2008; Swanson, 1982).  Our data 
are consistent with these findings, demonstrating that THVTA-LHb neurons do not 
collateralize to the NAc, BLA, PFC, or BNST. We also found that THVTA-LHb neurons 
display electrophysiological characteristics distinct from THVTA-NAc neurons. Notably, 
we found that THVTA-LHb neurons are more excitable than THVTA-NAc neurons, are 
insensitive to D2 autoreceptor activation, and do not display an Ih current, an 
electrophysiological characteristic often used to identify a neuron as dopaminergic in 
slice electrophysiological experiments (Mercuri et al., 1995).  Recent studies have 
demonstrated that although NAc-projecting and BLA-projecting VTA dopaminergic 
neurons typically have robust Ih currents, dopaminergic neurons that project to the 
mPFC lack Ih currents and functional somatodendritic D2 autoreceptors (Ford et al., 
2006; Lammel et al., 2008, 2011).  Collectively, these data support the idea that VTA 
dopaminergic neurons are not a homogenous population, as they can vary greatly 
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depending on their electrophysiological markers and their projection targets. 
Although THVTA-LHb neurons express TH mRNA and show TH immunostaining 
in the soma (Figure 3.3 and Figure 3.5), we observed only very weak TH 
expression in THVTA-LHb::ChR2 fibers and terminals (Figure 3.6).  Consistent with 
this, voltammetric methods failed to detect released dopamine in the LHb following 
optical stimulation of THVTA-LHb::ChR2 fibers. It is worth noting that we observed 
dense core vesicles in presynaptic terminals originating from THVTA-LHb neurons 
(Figure 3.7 H) Previous work has demonstrated that the vesicular monoamine 
transporter can be associated with dense core vesicles in VTA neurons, suggesting 
that dopamine may be contained in both clear synaptic vesicles and dense core 
vesicles (Nirenberg et al., 1996). It is possible that a low content of dopamine within 
the dense core vesicles in the LHb could be released following specific stimulation 
patterns, leading to concentrations of dopamine in the LHb too low to detect with 
voltammetric methods.  Additionally, because TH is produced in the soma, THVTA-LHb 
neurons may be releasing dopamine locally from the somatodendritic compartment, 
which could then activate D2 autoreceptors to modulate the firing rate of neighboring 
VTA neurons (Adell and Artigas, 2004). 
Previous studies have found that systemic injections of dopaminergic 
agonists and bath-application of high concentrations of dopamine result in changes 
in the firing patterns and glucose utilization of LHb neurons (Jhou et al., 2013; 
Kowski et al., 2009; McCulloch et al., 1980).  However, as dopaminergic agonists 
often have affinities for serotonin receptors (Newman-Tancredi et al., 2002), which 
are thought to reside on presynaptic terminals in the LHb (Shabel et al., 2012), it is 
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unclear whether the effects of these agonists on LHb activity arise from direct 
activation of dopamine receptors in the LHb. 
LHb neurons exhibit a high basal firing rate both in slices (Figure 3.7) (Jhou 
et al., 2013) and in vivo (Bromberg-Martin et al., 2010b; Meier and Herrling, 1993), 
which likely exerts a tonic inhibitory influence on dopaminergic neurons by activating 
RMTg GABAergic neurons that directly inhibit VTA dopaminergic neurons. 
Supporting this hypothesis, we found that inhibition of LHb neurons through 
activation of THVTA-LHb::ChR2 terminals decreased RMTg firing and increased the 
spontaneous firing rate of VTA dopaminergic neurons (Figure 3.9 and 3.10), 
consistent with previous data demonstrating that pharmacological inhibition of the 
LHb increases dopamine release in the forebrain (Lecourtier et al., 2008).  LHb 
neurons show a decrease in firing in response to cues that predict reward 
(Matsumoto and Hikosaka, 2007). Thus, we suggest that the phasic dopamine 
release seen in the NAc in response to motivationally relevant stimuli, at least in 
part, could require activation of inhibitory afferents to LHb, thus disinhibiting midbrain 
dopaminergic neurons. Data presented here demonstrate that a hybrid population of 
VTA neurons expressing dopaminergic and GABAergic markers send an inhibitory 
projection to the LHb and thus are able to directly inhibit LHb neurons, resulting in 
profound downstream effects on midbrain circuitry. This provides a circuit 
mechanism by which activation of the VTA-to-LHb pathway could promote reward. 
Along with a robust excitatory projection to GABAergic neurons in the RMTg 
and posterior VTA, the LHb also sends a modest direct glutamatergic projection to 
VTA dopaminergic neurons (Balcita-Pedicino et al., 2011; Stamatakis and Stuber, 
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2012).  If the VTA dopaminergic neurons that receive a direct connection from the 
LHb also project back to the LHb, this could provide an elegant negative feedback 
mechanism, whereby activation of the LHb would result in activation of THVTA-LHb 
neurons, which in turn would shut down LHb activity. 
Although the presence of a mesohabenular pathway has been recognized for 
many years (Phillipson and Griffith, 1980; Swanson, 1982), the present study 
characterizes the behavioral and functional relevance of this pathway. Our data add 
to the mounting evidence that dopaminergic neurons within the VTA are 
heterogeneous with respect to their electrophysiological and molecular profiles, their 
projection targets, and neurotransmitter signaling modalities. Further, our data 
demonstrate that the LHb and midbrain interact in a reciprocal manner and implicate 
the VTA’s projection to the LHb as a key node in the classical midbrain reward 
circuit. This mechanistic framework underscores the flexibility and complexity of the 
circuitry that impinges upon VTA dopaminergic neurons to promote motivated 
behavior. 
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FIGURES 
	  	  	  
Figure 3.1: THVTA neurons project to the LHb.  (A,B) Confocal images of coronal 
sections showing expression of ChR2-eYFP in the VTA following injection of Cre-
inducible virus into the VTA of a TH-IRES-Cre (THVTA::ChR2) mouse. (C) 
Quantification of TH+, eYFP+, and eYFP+ neurons that are also TH+ (n = 4 sections 
from n = 3 mice). (D,E) Confocal images of coronal sections showing expression of 
ChR2-eYFP fibers in the LHb of a THVTA::ChR2 mouse.  (F) eYFP fluorescence 
intensity is significantly higher in the LHb than in surrounding regions (F5,30 = 5.718, 
p < 0.0001; n = 6 sections from n = 3 mice). MHb, medial habenula; LHb, lateral 
habenula; DG, dentate gyrus; LDT, lateral dorsal thalamus; MDT, medial dorsal 
thalamus. Dagger symbol denotes significance compared to all manipulations.  All 
error bars for all figures correspond to the s.e.m. *indicates p < 0.05 and ** indicates 
p < 0.01 for all figures. 
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Figure 3.2: THVTA-LHb neurons are a distinct population of neurons. (A) HSV 
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vector maps.  LT HSV virus encoding a cre inducible flp recombinase was modified 
from previously published ST HSV vectors.  LT HSV results in longer term 
expression of introduced transgenes into neurons compared to standard (ST) HSV 
vectors.  (B) Diagram illustrates HSV-EF1α-LS1L-flp (HSV-flp) and AAV5-EF1α-
fdhChR2(H134R)-eYFP (FD-eYFP) viral injections. Confocal images show eYFP 
expression in the NAc (below) and LHb (right) following injection of HSV-flp into the 
LHb and FD-eYFP into the VTA of TH:IRES:Cre mice. (C) Schematic of HSV-flp and 
FD-eYFP viral injections.  Confocal images show eYFP expression in the NAc 
(below) and LHb (right) following HSV-flp into the NAc and FD-eYFP into the VTA of 
TH:IRES:Cre mice.   	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Figure 3.3: THVTA-LHb neurons are located in the medial-anterior portion of the 
VTA. (A) Left: schematic of retrobead injections. Right: confocal images of separate 
TH+ neurons containing NAc-injected beads (top) and LHb-injected beads (bottom). 
(B) Left: location of THVTA-NAc neurons (red) and THVTA-LHb neurons (green) from a 
representative animal. Right: more TH+ neurons in the VTA contained red 
retrobeads (THVTA-NAc neurons) than green retrobeads (THVTA-LHb neurons) (anterior: 
t8 = 3.01, p = 0.02; n = 5 sections from n = 4 mice; middle: t8 = 6.51, p = 0.0002; n = 
5 sections from n = 4 mice; posterior: t6 = 9.58, p < 0.0001; n = 4 sections from n = 4 
mice). Error bars represent SEM. ∗∗p < 0.01 (Student’s t test and ANOVA followed 
by Bonferroni post hoc comparisons, where applicable).  
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Figure 3.4: THVTA-LHb neurons exhibit distinct electrophysiological 
characteristics. (A) Top: VTA neuron (indicated by arrow) visualized with a DIC 
microscope. Bottom left: same neuron visualized under epifluorescent illumination 
with rhodamine filter. Bottom right: same neuron visualized under epifluorescent 
illumination with GFP filter.  (B) Left: representative traces showing Ih current in a 
THVTA-NAc neuron (top) and THVTA-LHb neuron (bottom) in response to voltage steps. 
Right: THVTA-LHb neurons show significantly less Ih current than THVTA-NAc neurons 
(t16 = 4.5, p = 0.0004; n = 10 THVTA-NAc neurons and 8 THVTA-LHb neurons).  (C) 
THVTA-LHb neurons have a higher membrane resistance than THVTA-NAc neurons (t16 = 
2.4, p = 0.03; n = 10 THVTA-NAc neurons and 8 THVTA-LHb neurons).  (D) 
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Representative traces showing spontaneous firing of THVTA-LHb neuron (purple) and 
THVTA-NAc neuron (green) during a baseline period (top) and following a bath 
application of a D2 agonist (3 µM quinpirole, bottom).  (E) Spontaneous firing is 
significantly higher in THVTA-LHb neurons than in THVTA-NAc neurons (t17 = 3.78, p = 
0.0015; n = 10 THVTA-NAc neurons and 9 THVTA-LHb neurons).  (F) Bath application 
(3 µM) of quinpirole decreases the spontaneous firing rate significantly more for 
THVTA-NAc neurons compared to THVTA-LHb neurons (F34,490 = 10.58, p = < 0.0001; n = 
9 THVTA-NAc neurons and 7 THVTA-LHb neurons. Error bars represent s.e.m. ∗p < 0.05 
∗∗p < 0.01 (Student’s t test and ANOVA followed by Bonferroni post hoc 
comparisons, where applicable). 
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Figure 3.5: THVTA-LHb neurons express lower amounts of mRNA for 
dopaminergic markers than THVTA-NAc neurons. (A) Schematic of single-cell RT-
PCR analysis.  (B) Percentage of THVTA-LHb and THVTA-NAc neurons expressing each 
gene (Vglut2, vesicular glutamate transporter-2; Vgat, vesicular GABA transporter; 
GAD1/GAD2, glutamate decarboxylase 1 and 2; Vmat2, vesicular monoamine 
transporter-2; DRD2, dopamine receptor D2; DAT1, dopamine transporter; and TH, 
tyrosine hydroxylase).  (C) Ct values for each target gene were normalized to the 
control gene expressed in all neurons, Rn18s, and log transformed fold expression 
values represent single cell expression relative to THVTA-NAc expression. The average 
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fold expression for Vmat2, DRD2, and DAT1 is significantly lower in THVTA-LHb 
neurons compared THVTA-NAc neurons (Vmat2: U = 19, p = 0.0136; DRD2: U = 10, 
p = 0.0053; DAT1: U = 17.00, p = 0.0069; n = 9 THVTA-LHb neurons from n = 4 mice 
and n = 12 THVTA-NAc neurons from n = 3 mice). Error bars represent SEM. ∗p < 0.05 
∗∗p < 0.01 (Mann-Whitney). 
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Figure 3.6: THVTA-LHb neurons do not release detectable levels of dopamine in 
the LHb (A) Fast-scan cyclic voltammetric recordings of optically-evoked dopamine 
release in LHb (left), NAc (middle), and BNST (right) brain slices from THVTA::ChR2 
mice. Top: example traces of voltammetric recordings from LHb (left), NAc (middle), 
and BNST (right) brain slices. Insets: background-subtracted cyclic voltammograms 
showing an electrochemical signal indicative of oxidized dopamine in the NAc and 
BNST, but not in the LHb. Bottom: consecutive background-subtracted 
voltammograms recorded over the 8 s interval. Applied potential (Eapps versus 
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Ag/AgCl reference electrode) is shown on y axis. Time at which each voltammogram 
was recorded is shown on x axis. Current changes are color-coded.  (B) Light-
evoked current is significantly higher in the NAc than LHb at 20 Hz for all measured 
number of pulses (F5,1 = 19.1, p < 0.0001). Light-evoked current is significantly 
higher in the BSNT than LHb at 20 Hz for 8, 16, and 32 pulses (F5,1 = 72.59, p < 
0.0001).  (C) Light-evoked current is significantly higher in the NAc than LHb for all 
measured frequencies (F4,1 = 29.11, p < 0.001). Light-evoked current is significantly 
higher in the BNST than LHb for 10 and 20 Hz (F4,1= 25.43, p < 0.001). (D) Confocal 
images showing eYFP- and TH-expression in the NAc (top), LHb (middle), and 
BNST (bottom) from THVTA::ChR2 coronal sections.  (E) eYFP fluorescence intensity 
is significantly higher in the NAc than in the LHb (t10 = 6.58, p < 0.0001). eYFP 
fluorescence intensity is not significantly different between the LHb and BNST (t10 = 
0.9002, p = 0.389). n = 6 slices/region from n = 3 mice.  (F) ChR2-eYFP and TH 
colocalize significantly less in the LHb than in the BNST and NAc (Pearson’s 
correlation coefficient, F2,12 = 76.49, p < 0.0001; n = 5 slices/region from n = 3 mice). 
Error bars represent s.e.m.. ∗∗p < 0.01 (Student’s t test and ANOVA followed by 
Bonferroni post hoc comparisons, where applicable). 	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Figure 3.7: THVTA-LHb neurons release GABA in the LHb. (A–C) Light-evoked 
IPSCs recorded from LHb neurons in the presence of 1 mM 4-AP and 1 µM TTX are 
blocked by bath-application of 10 µM gabazine (t12 = 3.12, p = 0.009; n = 7 neurons).  
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(D) Light-evoked IPSCs recorded from LHb neurons in normal aCSF and from 
reserpine-treated mice (t18 = 0.60; p = 0.56; n = 10 neurons each). (E–G) Cell-
attached recordings demonstrating a significant decrease in the spontaneous firing 
rate of LHb neurons in response to a 1 s 20 Hz optical stimulation of THVTA-
LHb::ChR2 terminals in the LHb in normal aCSF (baseline: t14 = 9.57, p < 0.0001) and 
after application of a D1/D2 antagonist (D1/D2: t14 = 7.76, p < 0.0001), but not after 
application of a GABAA receptor antagonist (gabazine: t14 = 1.05, p = 0.31) n = 10 
neurons.  (H) Electron micrographs showing THVTA-LHb::ChR2 fibers, as defined by 
large silver-enhanced nanogold particles (black arrows) containing GABA (detected 
with 10 nm gold particles, white arrows). THVTA-LHb::ChR2 fibers also contain dense-
core vesicles (red arrows). See also Figure S4. Error bars represent s.e.m. ∗∗p < 
0.01 (Student’s t test and ANOVA followed by Bonferroni post hoc comparisons, 
where applicable). 
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Figure 3.8: GABA-negative asymmetric THVTA-LHb::ChR2 synapse. (A) Electron 
micrograph showing THVTA-LHb::ChR2 presynaptic terminal, as defined by large 
silver-enhanced particles (black arrows) making an asymmetric synapse (red arrow 
pointing to postsynaptic density).  GABA (white arrow) is located in neighboring 
synapses, but not in THVTA-LHb::ChR2 presynaptic terminal.  	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Figure 3.9: In vivo optical stimulation of THVTA-LHb terminals suppresses RMTg 
activity. (A) A schematic depicting anesthetized in vivo electrophysiological 
recordings from RMTg neurons during THVTA-LHb terminal optical stimulation.  (B) 
Example trace from a single RMTg unit (top) and its representative peri-event 
histogram and raster (bottom) demonstrating repeated attenuation of firing to 20 Hz 
optical stimulation of the THVTA-LHb pathway.  (C) Off, On, Off: before, during, after 
20 Hz photostimulation (3 s each; 20 trials). The average firing rate of RMTg units 
significantly decreased during the 3 s 20 Hz optical stimulation trials (F2,15 = 4.33, 
p = 0.03, n = 3 mice, n = 6 units). (D) Confocal image of coronal section showing 
expression of ChR2-eYFP in the RMTg following injection of Cre-inducible virus into 
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the VTA of a TH-IRES-Cre (THVTA::ChR2) mouse.  We found that 3.02 ±	  0.422% of 
neurons were TH+.  We observed very minimal ChR2-eYFP expression in RMTg 
brain slices (less than 3 neurons per slice).  n = 4 slices from n = 4 mice.  (E) 
Schematic detailing RMTg in vivo recordings paired with optical stimulation of the 
recording region.  (F) Representative trace from a single non-optically excitable 
RMTg unit (top) and its representative peri-event histogram and raster (bottom) 
showing no response to optical stimulation of the RMTg. (G) The average firing rate 
of RMTg neurons did not significantly alter during 20-Hz optical stimulation when 
compared to the time epochs without stimulation (F2,15 = 0.057, p = 0.95, n = 3 mice, 
n = 6 units). Error bars represent s.e.m. (ANOVA followed by Bonferroni post-hoc 
comparisons).   	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Figure 3.10: In vivo optical stimulation of THVTA-LHb terminals enhances 
spontaneous firing of THVTA neurons (A) Schematic for anesthetized in vivo 
extracellular recordings in the VTA.  (B) Example traces from a single optically-
tagged THVTA unit displaying repeated time-locked activation to 2 ms optical 
stimulation of the VTA. (C) Example trace from a single THVTA unit (top) and its 
representative peri-event histogram and raster (bottom) displaying repeated time-
locked activation to 20 Hz optical stimulation of THVTA cell bodies.  (D) Example 
trace from a single THVTA unit (top) and its representative peri-event histogram and 
raster (bottom) displaying enhanced activity in response to 20 Hz optical stimulation 
of THVTA-LHb terminals within the LHb.  (E) The average firing rate of optically-
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identified THVTA units significantly increased during 20 Hz optical stimulation of 
THVTA-LHb terminals within the LHb (F2,12 = 10.02, p = 0.0028, n = 3 mice, n = 5 
units).  (F) The average latency of each optical stimulation parameter (soma versus 
terminal; left) demonstrates that optical stimulation of THVTA-LHb terminals resulted 
in significantly greater spike latencies in optically-identified THVTA neurons compared 
to light-evoked spikes from THVTA-soma optical stimulation (p = 0.0053, n = 3 mice, 
n = 9 units). The standard deviation (STDEV) of each stimulation type (right) shows 
that light-evoked spikes from THVTA-soma optical stimulation displayed significantly 
greater latency stability compared to THVTA-LHb-terminal initiated spikes (p = 0.0014, 
n = 3 mice, n = 9 units).  (G) THVTA-soma light-evoked spikes responded more 
reliably to 20 Hz optical stimulation compared to THVTA-LHb-terminal light-evoked 
spikes (F1,18 = 11.2, p = 0.0036, n = 3 mice, n = 11 units). Error bars represent s.e.m. 
∗∗p < 0.01 (Student’s t test and ANOVA followed by Bonferroni post hoc 
comparisons, where applicable).  
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Figure 3.11: Activation of THVTA-LHb terminals produces reward-related 
behavioral phenotypes . (A) Representative tracks from THVTA-LHb::Control (top) 
and THVTA-LHb::ChR2 (bottom) mice during RTPP task.  (B,C) THVTA-LHb::ChR2 mice 
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spent more time on the side of the chamber paired with stimulation than THVTA-
LHb::Control mice (5 min time bins: F3,1 = 79.2, p < 0.0001; entire 20 min session: 
t13 = 8.82, p < 0.0001; n = 8 THVTA-LHb::Control and 7 THVTA-LHb::ChR2). (D) Intra-LHb 
injections of a GABAA antagonist, but not a dopamine receptor (D1 and D2) 
antagonist cocktail, followed by THVTA-LHb::ChR2 stimulation blocked the real-time 
place preference (F3,32 = 5.1, p = 0.005; n = 9 mice). (E) Systemic injection of a 
dopamine receptor (D1 and D2) antagonist cocktail followed by THVTA-LHb::ChR2 
stimulation blocked the real-time place preference (t12 = 4.0, p = 0.002; n = 7 mice).  
(F) Active nose-poke responses from THVTA-LHb::ChR2 and THVTA-LHb::Control mice 
over the first 5 days of training. THVTA-LHb::ChR2 mice made significantly more nose-
pokes on Days 3, 4, and 5 than THVTA-LHb::Control mice (Day 3: t12 = 3.78, p < 0.01; 
Day 4: t12 = 4.45, p < 0.001; Day 5: t12 = 4.22, p < 0.001).  (G) Example cumulative 
records of nose-pokes made by a THVTA-LHb::ChR2 mouse for 0, 1, 10, 20, and 40 Hz 
optical stimulation in the 5-choice nose-poke task.  (H) THVTA-LHb::ChR2 mice made 
significantly more nose-pokes for 40 Hz than any other frequency (F4,25 = 9.13, p < 
0.0001). n = 6 THVTA-LHb::ChR2 mice. n = 8 THVTA-LHb::Control mice. Dagger symbol 
denotes significance compared to all manipulations. Error bars represent s.e.m. 
∗∗p < 0.01 (Student’s t test and ANOVA followed by Bonferroni post hoc 
comparisons, where applicable). 	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CHAPTER 4: A MAJOR GLUTAMATERGIC LATERAL HABENULA AFFERENT 
FROM THE LATERAL HYPOTHALAMUS NEGATIVELY CONTROLS FEEDING 
AND REWRAD 
 
INTRODUCTION 
The initiation and coordination of complex motivated behaviors, such as the 
seeking out and consumption of food, is necessary for an organism’s survival.  
Identifying the precise brain regions and neural circuits that direct these behaviors 
will be necessary to understand neuropsychiatric diseases, such as eating disorders 
and addiction, that may occur when these circuits become perturbed.  The lateral 
hypothalamus (LH) is a large heterogeneous structure involved in many processes 
aimed at maintaining homeostasis (Lein et al., 2007; Markakis, 2002; Sternson et al., 
2013).  Early electrical stimulation studies of the LH revealed that activation 
produces robust feeding, as well as reward-seeking behavior (DELGADO and 
ANAND, 1953; Hoebel and Teitelbaum, 1962; Margules and Olds, 1962; Olds and 
Milner, 1954).  However, as the LH is composed of many genetically distinct 
neuronal subtypes, such as GABAergic, glutamatergic, peptidergic, and 
monoaminergic neurons, and contains many afferents and fibers of passage, it is 
unclear which neural substrate is responsible for producing these behaviors.   
A recent circuit-based study demonstrated that the extended amygdala sends 
a robust inhibitory projection to the LH and preferentially synapses onto LH 
glutamatergic neurons (Jennings et al., 2013b).  Activation of this inhibitory input 
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results in time-locked feeding and reinforcement behaviors.  Further, direct 
optogenetic inhibition of the glutamatergic neurons in the LH promoted feeding and 
reward, while activation of these neurons suppressed feeding and produced 
aversion.  While it is clear that extended amygdala inputs to LH glutamatergic 
neurons promotes feeding and reward-seeking, it is unclear whether LH 
glutamatergic neurons regulate behavior or longer timescales, or if select projections 
from these cells underlie varying aspects of feeding and reward-seeking.  The LH 
projects to widespread regions of the brain, including the lateral habenula (LHb), 
midbrain, and hindbrain (Ching Liang Shen, 1983).  Here, we focus on the LH’s 
projection to the LHb to determine if this circuit underlies distinct aspects of feeding 
and reward-seeking. 
The LHb encodes aversive events and is involved in negative reward 
processing.  Functionally, LHb neurons show opposite responses to midbrain 
dopaminergic neurons during aversive and rewarding events.  Specifically, midbrain 
dopaminergic neurons show increases in firing to cues that predict a reward and 
decreased firing to cues that predict no reward, whereas LHb neurons respond in an 
opposite manner (Matsumoto and Hikosaka, 2007).  Importantly, excitation of LHb 
neurons precedes the inhibition of dopaminergic neurons.  LHb glutamatergic 
neurons inhibit VTA dopaminergic neurons by activating GABAergic rostromedial 
tegmental nucleus (RMTg) neurons that synapse onto dopaminergic VTA neurons, 
and activation of this circuit is aversive and disrupts ongoing positive reinforcement 
(Matsui and Williams, 2011; Stamatakis and Stuber, 2012).  Inputs from the LHb 
arise from forebrain regions including the LH, entopenduncular nucleus, and 
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prefrontal cortex (Kim and Lee, 2012; Poller et al., 2013; Shabel et al., 2012; 
Warden et al., 2012).  Because the LH is involved in maintaining homeostasis, and 
the LHb is a potent modulator of midbrain dopaminergic activity, we sought to 
determine whether the LH input to the LHb could be driving aspects of reward and 
feeding.  
Here, we report that genetic ablation of LH glutamatergic neurons increases 
feeding and weight gain on a long-term scale.  Additionally, we demonstrate that LH 
glutamatergic neurons send a functional glutamatergic projection to the LHb, and 
that this circuit is important for regulating aspects of feeding and motivated 
behaviors.  
 
METHODS 
Subjects 
Adult (25 – 30 g) male VGlut2-IRES-Cre or wild-type litter mates and adult 
(25-30 g) C57BL/6J mice were used.  Mice were maintained on a reverse 12-hr light 
cycle (lights off at 07:00) with ad libitum access to food and water unless placed on a 
food restriction schedule for the free-licking experiment (see below).  All food-
deprived mice were restricted to 90% of their initial body weight by administering one 
daily feeding of 2.5 – 3.0 g of standard grain-based chow (immediately following 
behavioral experiment, if performed).  All procedures were conducted in accordance 
with the Guide for the Care and Use of Laboratory Animals, as adopted by the NIH, 
and with approval of the Institutional Animal Care and Use Committee at the 
University of North Carolina at Chapel Hill.  
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Viral Construct   
Purified and concentrated adeno-associated viruses coding for Cre-inducible 
ChR2-eYFP (AAV5-EF1a-DIO-hChR2(H134R)-eYFP), NpHR3.0-eYFP (AAV5-
EF1a-DIO-NpHR3.0-eYFP), and taCasp3 (AAV2-FLEX-taCasp3-TEVp) were all 
packaged by the UNC Vector Core Facility at titres of ~2 x 1012 cfu per mil.   
 
Stereotactic Surgeries 
Mice were anesthetized with ketamine (150mg/kg body weight) and xylazine 
(50mg/kg) solution and placed in a stereotactic frame (Kopf instruments).  For the 
genetic ablation and optogenetic experiments, adult male VGlut2-IRES-Cre positive 
and negative littermates (Controls) were bilaterally microinjected with 0.3 µl of virus 
into the LH using the following coordinates: -1.0 mm posterior to bregma, ±0.9 mm 
lateral to midline, and -6.0 mm ventral to skull surface.  For the optogenetic 
experiments, mice were bilaterally implanted with optical fibers aimed directly above 
the LHb at -1.7 mm posterior to bregma, ±-1.25 lateral to midline, and -3.24 ventral 
to the skull surface at a 15° angle.  For the retrobead mapping and quantification 
experiments, male C57Bl/6J mice (Jackson Laboratory) received quadrouple 
injections (Nanoinject) with 70nL of red retrobeads (Lumafluor) in the LHb using the 
following coordinates: -1.4 mm and -1.8 mm posterior to bregma, ± 0.43 mm lateral 
to the midline and -3.3 ventral to the skull surface.  
 
Fluorescence in Situ Hybridization 
Mice were rapidly decapitated, and brains were snap frozen with dry ice in an 
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embedding mold of O.C.T Compound (Fisher Scientific, Pitssburgh, PA).  Fresh, 
frozen brains were sectioned at 20 µm on a cryostat (CM3050; Leica Biosystems, 
Richmond, VA) onto charged slides (Leica Biosystems, Richmond, VA).  A given set 
was hybridized to VGlut2 antisense and sense riboprobes.  A 1749-bp riboprobe 
complementary to VGlut2-sense cDNA that was inserted into the pGEM-4Z vector 
(Promega, Madison, WI).  Plasmid DNA was cut with either EcoRI or SalI in order to 
create a template for in vitro transcription.  All probes were created using digoxigenin 
(DIG)-labeled nucleotides for detection.  The SalI template was transcribed with Sp6 
RNA Polymerase to generate the sense riboprobe, and the EcoRI template was 
transcribed with T7 RNA polymerase to generate the antisense riboprobe.  
Fluorescence in situ hybridization (FISH) was performed at room temperature unless 
otherwise indicated.  Tissue was dried at 50 °C, fixed in 4% DEPC-PFA for 15 min, 
and washed in DEPC-PBS 3 x 5 min.  The tissue was then acetylated in 1x 
triethanolamine-HCl with 0.25% acetic anhydride for 10 min and subsequently 
washed in DEPC-PBS 3 x 5 min each.  Next, the tissue was prehybridized for 3 hr at 
65 °C in hybridization buffer containing 5X saline sodium citrate (SSC), 50% 
formamide, 1-mg/mL yeast tRNA, 0.1-mg/mL heparin, 0.1% tween-20, 0.005-M 
EDTA (pH 8.0), and 0.1% CHAPS.  Following prehybridization, the tissue was 
hybridized by incubating in hybridization buffer containing a probe for VGlut2 (DIG-
labeled).  Post-hybridization stringency washes were performed sequentially at 65 
°C in pre-warmed buffers: 1 x 15 min in 2X SSC, 3 x 20 min in 0.2X SSC buffer.  
Following stringency washes, tissue was further washed at room temperature 2 x 10 
min in Ts7.5 (0.1-M TRIS-HCl, pH 7.5, 0.15-M NaCl).  Tissue was then incubated in 
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3% H2O2 in methanol and washed 3 x 5 in TS7.5 to eliminate endogenous hydrogen 
peroxidase activity.  Sections were then incubated for 1 hr in 1% blocking buffer 
(Perkin Elmer, Waltham, MA), followed by incubation for 24 hr at 4 °C in anti-DIG-
POD (1:100 dilution in 1% blocking buffer).  The following day, after washing 3 x 10 
min in TNT wash buffer (0.1-M TRIS-HCl, pH 7.5. 0.15-M NaCl, 0.05% Tween-20), 
sections underwent a tyramide signal amplification with TSA plus DNP 1:50 in 
amplification diluent.  Following a 4-min incubation, sections were vigorously washed 
with TNT wash buffer 4 x 10 min and incubated in a DNP primary antibody 
conjugated with Alexa Fluor 488 (1:500 dilution in TNT; Molecular Probes, Eugene, 
Oregon) at 4 °C overnight.  Sections were then washed 3 x 10 min with TNT wash 
buffer and coverslipped with a mounting media containing DAPI as a counterstain 
(Life Technologies, Carlsbad, CA).  
 
Histology, immunohistochemistry, and confocal microscopy 
Mice were anesthetized with pentobarbital, and transcardially perfused with 
PBS followed by 4% (w/v) paraformaldehyde in PBS.  Brains were then removed 
and submerged in 4% paraformaldehyde for 24 hr and transferred to 30% sucrose in 
ddH2O for 48 hr.  40 mm brain sections were obtained and subjected to 
immunohistochemical staining for neuronal cell bodies (NeuroTrace Invitrogen; 640-
nm excitation/660-nm emission or 435-nm excitation/455-nm emission).  Brain 
sections were mounted, and z-stack and tiled images were captured on a Zeiss LSM 
710 confocal microscope using a 20x, 40x, or 63x objective and analyzed using ZEN 
2009 and ImageJ software.  To determine optical fiber placement, tissue was 
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imaged at 10X and 20X on an upright conventional fluorescent microscope.  
Free Feeding Following LH Glutamatergic Genetic Ablation 
Following surgery, VGlut2LH::taCasp3 and VGlut2LH::Control mice were 
weighed daily.  For 4 weeks, mice were given ad libitum access to standard grain-
based chow (Harlan, 3.5 calories/gram).  Chow was weighed daily immediately 
following weighing of mice.  After 4 weeks of access to grain-based chow, mice were 
given ad libitum access to both standard grain-based chow and a calorie-dense 
chow (Bioserv, High Fat diet, Gat Calories = 60%, 5.49 calories/gram).  Body weight, 
grain-based chow, and calorie-dense chow were weighed daily.  Calories consumed 
were calculated by grams of grain-based chow (3.5 calories/gram) plus grams of 
calorie-dense chow (5.49 calories/gram). 
Open Field Testing 
4 weeks following surgery, VGlut2LH::taCasp3 and VGlut2LH::Control mice 
were examined in a custom made open field arena (25 x 25 x 25 cm white plexiglass 
arena) for 35 min.  Center zone was defined as the center 156 cm2 (25% of the 
entire arena).  Corner zones were defined as the 39 cm2 in each corner.  The 35 min 
session was recorded with a CCD camera that was interfaced with Ethovision 
software (Noldus Information Technologies).  Time spent in the corner and the 
center of the open-field apparatus was recorded.  
Patch-Clamp Electrophysiology 
Mice were anesthetized with pentobarbital and perfused transcardially with 
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modified artificial cerebrospinal fluid containing (in mM): 225 sucrose, 119 NaCl, 1.0 
NaH2PO4, 4.9 MgCl2, 0.1 CaCl2, 26.2 NaHCo3, 1.25 glucose.  Brains were then 
rapidly removed and placed in the same solution that was used for perfusion at ~0 
°C.  Coronal slices containing the LHb (200 µm) were cut on a Vibratome (VT-1200, 
Leica Microsystems).  Following slicing, brain slices were placed in a holding 
chamber and were allowed to recover for at least 30 minutes before being placed in 
the recording chamber and superfused with bicarbonate-buffered solution saturated 
with 95% O2 and 5% CO2 containing (in mM): 119 NaCl, 2.5 KCl, 1.0 NaH2PO4, 1.3 
MgCl2, 2.5 CaCl2, 26.2 NaHCO3, and 11 glucose (at 32-34°C).  Cells were 
visualized using infrared differential contrast and fluorescence microscopy.  For 
voltage-clamp recordings, patch electrodes (3-5 MΩ) were back-filled with a cesium 
methanesulfonic acid internal solution containing (in mM): 117 Cs methanesulfonic 
acid, 20 HEPES, 0.4 EGTA, 2.8 NaCl, 5 TEA, 2 ATP, 0.2 GTP.  For cell-attached 
recordings, patch electrodes (2-4 MΩ) were back-filled with a potassium gluconate 
internal solution containing (in mM): 130 K-gluconate, 10KCl, 10 HEPES, 10 EGTA, 
2 MgCl2, 2ATP, 0.2 GTP.  pH = 7.35, 270-285 mOsm for all internal solutions.  
Whole-cell voltage-clamp, and cell-attached recordings of LHb neurons were made 
using an Axopatch 700B amplifier (Molecular Devices).  For all optical stimulations, 
blue light (1 mW, 473 nm) was delivered through a 40X objective via a LED.  Series 
resistance (15-25 MΩ) and/or input resistance were monitored online with a 5-mV 
hyperpolarizing step delivered between stimulation sweeps.  All data were filtered at 
2kHz, digitized at 5-10kHz, and collected using pClamp10 software (Molecular 
Devices). For the voltage-clamp recordings in LHb neurons, membrane potentials 
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were maintained at -70mV, and then at +10mV, and light pulses were delivered 
every 20 s to evoke neuronal firing. For EPSCs, following 5-10 min of baseline 
recording, 10 µM of the glutamate antagonist DNQX was bath-applied for 10 min.  
For IPSCs, following 5-10 min of baseline recording, 10µM of the GABAA receptor 
antagonist, SR-95531 (gabazine) was bath-applied for 10 min. IPSC and EPSC 
amplitudes were calculated by measuring the peak current from the average 
response from 6 sweeps during baseline and during each drug application. Cells that 
showed a > 20% change in the holding current or access resistance were excluded 
from analysis.  For cell-attached recordings, a 20-Hz optical stimulation was 
delivered for 1 s every 20 s for 20 sweeps.  Firing rate was averaged across all 20 
sweeps.  
Real-time place preference 
VGlut2LH-LHb::ChR2, VGlut2LH-LHb::NpHR3.0, and VGlut2LH-LHb::Control mice 
bilaterally implanted with optical fibers aimed at the LHb were placed in a custom-
made behavioral arena (50 × 50 × 25 cm black plexiglass) for 20 min. One 
counterbalanced side of the chamber was assigned as the stimulation side. At the 
start of the session, the mouse was placed in the non-stimulated side of the 
chamber.  Every time the mouse crossed to the stimulation side of the chamber, a 
20-Hz constant laser stimulation (472 nm for VGlut2LH-LHb::ChR2 mice) or a constant 
532 nm laser stimulation (for VGlut2LH-LHb::NpHR3.0) was delivered until the mouse 
crossed back into the non-stimulation side.  Percent time spent on the stimulation-
paired and velocity was recorded via a CCD camera interfaced with Ethovision 
software (Noldus Information Technologies).   
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Photoinhibition of VGlut2LHàLHb::NpHR3.0 during consumption behavioral 
assays 
Following the real time place preference experiments, male VGlut2LH-
LHb::NpHR3.0 and VGlut2LH-LHb::Control mice were restricted to 90% of their initial 
body weight by administering one daily feeding of ~ 2.5 to 3.0 g of standard grain-
based chow immediately following each behavioral experiment, if performed.  
Behavioral training and testing occurred in mouse operant chambers interfaced with 
optogenetic stimulation equipment as described previously (Stamatakis and Stuber, 
2012).  Once mice reached 90% of their body weight, they were trained in a 
standard behavioral box (Med Associates, Vermont, USA) equipped with two bottle 
lickometers for quantification of consumption of a highly palatable liquid (Ensure). 
The free-reward consumption task consisted of unlimited access to Ensure during 
each 20 min session. Lick time stamps were recorded and used for analysis.  Mice 
were trained until the number of licks during each session was stable (<20% 
change) for three consecutive sessions, which for all mice occurred after 7-15 
training sessions. Once the mice stabilized they received constant optical inhibition 
during a 20 min session (532 nm light from a solid-state laser delivered via custom-
made patch cables).  
 
RESULTS 
Genetic Ablation of VGlut2LH Neurons Increases Caloric Intake and Body 
Weight 
Optogenetic inhibition of glutamatergic neurons in the LH results in time-
locked increases in feeding (Jennings et al., 2013b); however, it is unclear if these 
neurons are important in regulating feeding or body weight over days or weeks.  
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Therefore, we selectively ablated glutamatergic neurons in the LH by injecting a cre-
dependent virus (AAV-FLEX-taCasp3-TEVp) encoding pro-taCaspase-3 and a TEVp 
enzyme that cleaves pro-taCaspase-3 into the active, proapoptotic signal caspase-3 
into Vesicular glutamate transporter-2 (VGlut2)-cre mice (Figure 4.1A).  Following 
virus injections, in situ hybridization revealed a significant reduction in the number of 
LH neurons that expressed vglut2 (Figure 4.1 B-E).  We also observed a reduction 
in the neighboring ventromedial hypothalamus, although to a lesser extent (Figure 
4.1 B-E).  We observed no differences in body weight or caloric intake when mice 
were had ad libitum access to standard rodent chow (Figure 4.1 F).  However, when 
mice were exposed to a calorie-dense diet, VGlut2LH:taCasp3 mice showed a 
significant increase in body weight and caloric intake compared to VGlut2LH:Control 
mice (Figure 4.1 F,G).   
To determine whether ablation of LH glutamatergic neurons resulted in 
changes in locomotor activity or anxiety-like phenotypes, which could account for a 
change in feeding, we next tested mice in an open-field assay. Although we 
observed a slight increase in locomotor activity (Figure 4.1 H,I), and a slight 
decrease in the amount of time spent in the center of the open-field (Figure 4.1 J,K), 
these results did not reach statistical significance.  
 
LHb-projecting LH neurons are glutamatergic and are localized to the anterior 
LH 
The lateral hypothalamus sends widespread projections throughout the brain, 
including to the LHb, the midbrain and hindbrain (Ching Liang Shen, 1983).  The 
projection from the LH to the LHb is almost strictly glutamatergic (Poller et al., 2013), 
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and thus we focused on this projection, since the LHb is critical for inhibiting and 
promoting aspects of motivated behaviors (Stamatakis and Stuber, 2012; 
Stamatakis et al., 2013).  To provide an anatomical map of the LHb-projecting LH 
neurons within the LH, we injected fluorescent retrograde beads into the LHb of wild-
type mice (Figure 4.2 A,B).  Three weeks following surgery, we observed neurons in 
the LH and entopenduncular nucleus labeled with retrogradely transported beads 
from the LHb.  While LHb-projecting LH neurons spanned the length of the LH, we 
observed the highest density of LHb-projecting LH neurons in the anterior portion of 
the LH (Figure 4.2 C).   
Confocal and electron microscopy studies have revealed that the majority of 
LH presynaptic terminals in the LHb contain VGlut2, but lack the GABA-synthesizing 
enzyme glutamate decarboxylase (GAD) (Poller et al., 2013). To selectively target 
LH glutamatergic neurons and confirm that the LH-to-LHb pathway was 
glutamatergic, we introduced a cre-inducible viral construct coding for 
channelrhodopsin-2 conjugated to enhanced yellow fluorescent protein (ChR2-
eYFP) bilaterally into the LH of VGlut2-Cre mice (Figure 4.2 D). Six weeks following 
surgery, we observed robust eYFP expression in the LH as well as in fibers from the 
LH that innervate the LHb (Figure 4.2 E,F).  To explore whether there was a 
GABAergic projection from the LH, we introduced a cre-inducible viral construct 
coding for ChR2-eYFP bilaterally into the LH of Vgat-Cre adult mice as well (Figure 
4.2 G). Six weeks following surgery, we observed robust eYFP expression in the LH 
and in regions surrounding the LHb, such as the thalamus, but only observed very 
modest eYFP expression in the LHb (Figure 4.2 G-I).  Collectively, these data 
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support earlier findings demonstrating a primarily glutamatergic input from the LH to 
the LHb.  
 
Characterization of neurotransmitter release from VGlut2LH-LHb fibers 
We next sought to confirm that LH glutamatergic neurons functionally project 
to LHb neurons and release glutamate.  We performed whole-cell voltage-clamped 
recordings from postsynaptic LHb neurons in brain slices obtained from 
VGlut2LH::ChR2 mice.  Voltage-clamp recordings from LHb neurons revealed that 
light pulses that selectively stimulated VGlut2LH::ChR2 fibers in the LHb, produced 
light-evoked currents that were blocked by the glutamate receptor antagonist DNQX 
(n = 25 cells, 76% were light responsive) (Figure 4.3 A,B).  At the reversal potential 
for AMPA receptors, we observed a small amplitude light-evoked current that was 
blocked by the GABAA receptor antagonist, gabazine (n = 8 cells, 50% were light 
responsive) (Figure 4.3 C,D).  Since we observed both excitatory and inhibitory 
components from VGlut2LH-LHb::ChR2 terminals, we next investigated how activating 
VGlut2LH-LHb::ChR2 terminals would affect the spontaneous firing rate of postsynaptic 
LHb neurons.  To accomplish this, we performed cell-attached recordings from LHb 
neurons and found that when we delivered a 1s 20 Hz optical pulse-train to 
selectively stimulate VGlut2LH::ChR2 terminals, the majority of LHb neurons showed 
increases in firing (70.6%) (Figure 4.3 E-G).  We also observed a much smaller 
population of LHb neurons that demonstrated a decrease in spontaneous firing 
following optical stimulation (5.9%) (Figure 4.3 H-J).  These data suggest that while 
LH glutamatergic neurons might be co-releasing GABA, the net effect of 
	   123	  
neurotransmitter release of stimulating VGlut2LH::ChR2 terminals is to increase the 
firing rate of LHb neurons.  
 
Optical stimulation and inhibition of LH-to-LHb pathway bidirectionally 
modulates reward-seeking behavior    
Given that optogenetic activation of LH glutamatergic neurons produces 
aversive phenotypes (Jennings et al., 2013b), and that the LH sends a dense 
projection to the LHb (Figure 4.2 E), we explored the functional role of the LH-to-
LHb circuit in modulating reward-seeking using in vivo optogenetics.  To selectively 
control the LH-to-LHb circuit, we injected VGlut2-Cre mice with either cre-inducible 
ChR2-eYFP (Figure 4.2D; VGlut2LH-LHb::ChR2), cre-inducible eYFP (VGlut2LH-
LHb::Control), or cre-inducible halorhodopsin3.0 (VGlut2LH-LHb::NpHR3.0),  and 
bilaterally implanted optical fibers aimed above the LHb (Figure 4.4 A).    
Approximately 6 weeks after surgery, we tested whether direct optical 
activation or inhibition of VGlut2LH-LHb afferents in the LHb influences feeding and 
reward-related behavioral phenotypes.  Activation of VGlut2LH-LHb terminals 
decreased time spent in a location paired with optical stimulation, while inhibition of 
VGlut2LH-LHb terminals increased time spent in a location paired with optical inhibition 
(Figure 4.4 C-E).  VGlut2LH-LHb::NphR3.0 and VGlut2LH-LHb::Control mice were then 
food restricted to 90% of their free-feeding body weight to assess whether the 
VGlut2LH-LHb circuit is necessary to promote aspects of feeding.  Mice were given 
free access to a highly palatable calorically dense liquid for 20 minutes.  Once mice 
displayed stable baseline drinking behavior (<20% difference across 3 days), mice 
were exposed to constant optical inhibition of the VGlut2LH-LHb circuit during the 
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entire 20-minute session.  Optical inhibition of the circuit resulted in a significant 
increase in drinking in VGlut2LH-LHb::NphR3.0 mice, compared to VGlut2LH-
LHb::Control mice (Figure 4.4 F-I).  These data suggest the glutamatergic projections 
from the LH to the LHb may serve as a valence detector, by increasing 
glutamatergic tone to promote avoidance, or decreasing glutamatergic tone in the 
LHb to promote ongoing rewarding behavior.  
 
DISCUSSION 
The LH has been long recognized as a critical brain region for both feeding 
and reward-seeking (Hoebel and Teitelbaum, 1962; Margules and Olds, 1962).  
However, given the rich cellular heterogeneity and distributed afferent and efferent 
connectivity, it has been difficult to understand the precise LH circuit connectivity 
that controls distinct aspects of motivated behaviors.  Electrical stimulation of the LH 
causes voracious feeding and reward-seeking behavior (DELGADO and ANAND, 
1953; Olds and Milner, 1954), yet activation of glutamatergic neurons in the LH 
disrupts feeding and causes avoidance behaviors (Jennings et al., 2013b).  
Interestingly, lesions of the LH can result in weight loss and significant aphagia (Von 
Der Porten and Davis, 1979; Harrell et al., 1975; Schallert and Whishaw, 1978). 
However, here we demonstrate that genetic ablation of LH glutamatergic neurons 
causes increases in caloric intake and increased body weight after weeks of access 
to a high fat diet, suggesting that LH glutamatergic neurons may be involved in long-
term homeostatic feeding mechanisms, such as metabolism regulation.  The LH 
contains GABAergic neurons as well as glutamatergic neurons, and in situ data 
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suggest that the population of GABAergic LH neurons may be larger than the 
population of glutamatergic neurons (Meister, 2007; Rosin et al., 2003).  These data 
underscore the heterogeneity of the LH and demonstrate that different genetically 
distinct cell groups can have profound differences on feeding behaviors.  
Since we observed an effect on feeding and body weight with genetic ablation 
of LH glutamatergic neurons, we next sought to investigate an output of the LH, 
which may be mediating these effects.  We found that the LH sends a strong 
projection to the LHb, an area involved in promoting negative reward behaviors.  
Optogenetic manipulation of this circuit resulted in a bidirectional effect on motivated 
behavior.  Activation of the LH-to-LHb circuit was aversive, while inhibition of the 
circuit was rewarding.  Previous data has demonstrated a similar aversive 
phenotype when activating inputs from the entopenduncular nucleus, an output of 
the basal ganglia (Shabel et al., 2012).  It is important to note that the 
entopenduncular nucleus and lateral hypothalamus are neighboring structures and it 
is possible that viral targeting of one region could result in viral transduction of the 
neighboring region.  Following retrobead injections into the LHb, we observed LHb-
projecting neurons in both the entopenduncular nucleus and the LH.  However, the 
entopenduncular nucleus, and the globus pallidus internus (the primate homolog) 
contains mainly GABAergic neurons (Oertel et al., 1984; Stephenson et al., 2005).  
In addition, our method for targeting the LH glutamatergic neurons, using cre-
inducible ChR2, did not result in significant infection of entopenduncular neurons 
(Figure 4.2 E), supporting our conclusions that our behavioral phenotypes are the 
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result of the modulation of LH afferents, rather than entopenduncular nucleus 
afferents.  
We observed both excitatory and inhibitory responses in LHb neurons 
following optical stimulation of VGlut2LH-LHb fibers (Figure 4.3).  This could be due to 
co-release of GABA and glutamate from the same LH neuron, or due to ectopic cre 
expression in non-glutamatergic LH neurons.  Previous studies have demonstrated 
specificity for cre-inducible viruses to target glutamate neurons in other brain regions 
in the VGlut2-Cre mouse, such as the bed nucleus of the stria terminalis (Jennings 
et al., 2013b).  However, it is unclear if this is the case in the LH, and thus further 
studies should be conducted to determine if LH neurons are capable of co-releasing 
both glutamate and GABA.  
Regulating homeostatic processes likely requires strong recruitment from the 
reward system.  Here, we demonstrate a robust, and behaviorally relevant, 
projection from the LH to the LHb.  Previous studies have demonstrated a prominent 
role for the LHb in regulating midbrain reward circuits.  Combined, these data 
suggest that the LHb may recruit reward circuits to drive motivated behaviors 
towards maintaining homeostasis.  
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FIGURES 
 
Figure 4.1: Genetic Ablation of LH Glutamatergic Neurons Increases Caloric 
Intake and Weight Gain. (A) Schematic for viral injection of AAV2-FLEX-taCasp3-
TEVp into the LH of VGlut2-IRES-Cre mice.  (B and C) 20x confocal images 
demonstrating decreased VGlut2 expression in VGlut2LH::taCasp3 (B) compared to 
VGlut2LH::Control (C) mice.  LH: lateral hypothalamus, Fx: fornix, DMH: dorsomedial 
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hypothalamic nucleus, VMH: ventromedial hypothalamic nucleus, 3V: third ventricle, 
D: dorsal, L: lateral, M: medial, V: ventral.  Scale bars, 200 µm.  (D) VGlut2 
expression is significantly decreased in the LH (n = 5 slices per group, t8 = 7.054, p 
< 0.0001) and VMH (n = 5 slices per group, t8 = 2.88, p = 0.02) of VGlut2LH::taCasp3 
mice compared to VGlut2LH::Controls.  (E) Injection of AAV2-FLEX-taCasp-TEVp 
into the LH of VGlut2-IRES-Cre mice resulted in a 59.23± 2.8% decrease in 
glutamate cells in the LH and a 27.47± 10.8% decrease in glutamatergic neurons in 
the VMH in VGlut2LH::taCasp3 mice.  (F) Ablation of LH glutamatergic neurons 
significantly potentiated weight gain induced from a calorie-dense diet (n=8 per 
group, F1,21 = 39.27, p < 0.001).  (G) Ablation of LH glutamatergic neurons 
significantly increased caloric intake as measured by the average daily calories 
consumed over the last 7 days of exposure to the calorie-dense diet (n = 8 per 
group, t14 = 4.50, p < 0.001).  (H,I) Open-field velocity was not significantly different 
between VGlut2LH::taCasp3 and VGlut2LH::Control mice (n = 9 per group, t16 = 0.57 , 
p = 0.58).  (J, K) Open-field center time was not significantly different between 
VGlut2LH::taCasp3 and VGlut2LH::Control mice (n = 9 per group, t16 = 1.13, p = 0.27).  
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Figure 4.2: The anterior LH sends a glutamatergic projection to the LHb. (A) 
Schematic for injection of red retrobeads into the LHb of a C57BL/6J mouse.  (B) 
Confocal image of the LH showing LHb-projecting LH neurons.  (C) Quantification of 
LHb-projecting LH neurons along the anterior-posterior axis of the LH. Ant: Anterior, 
Post: Posterior.  (D) Schematic for viral injection of AAV5-AAV5-EF1a-DIO-ChR2-
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eYFP into the LH of VGlut2-IRES-Cre mice (VGlut2LH::ChR2). (E) Confocal images 
of coronal sections showing expression of ChR2-eYFP in the LH and LHb (inset) of 
a VGlut2LH::ChR2 mouse. Scale bar, 100 µm.  (F) VGlut2LH-LHb::ChR2 eYFP 
fluorescence intensity is significantly higher in the LHb than in surrounding regions 
(F5,41 = 43.92, p < 0.0001; n = 8 sections from n = 2 mice). MHb, medial habenula; 
LHb, lateral habenula; DG, dentate gyrus; LDT, lateral dorsal thalamus; MDT, medial 
dorsal thalamus. (G) Schematic for viral injection of AAV5-EF1a-DIO-ChR2-eYFP 
into the LH of Vgat-IRES-Cre mice. (H) Confocal images of coronal sections 
showing expression of ChR2-eYFP in the LH and sparse ChR2-eYFP expression in 
the LHb (inset) of a Vgat-IRES-Cre mouse. Scale bar, 100 µm.  (I) VGatLH-LHb::ChR2 
eYFP fluorescence intensity is significantly higher in the MDT than in surrounding 
regions (F5,42 = 115.1, p < 0.0001; n = 8 sections from n = 2 mice).  
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Figure 4.3: Characterization of neurotransmitter release from VGlut2LH-
LHb::ChR2 terminals (A-B) Postsynaptic light-evoked EPSCs recorded from LHb 
neurons at -70mV are significantly attenuated following bath-application of 10 µM 
DNQX (n = 10 cells, t10 =2.37, p = 0.039). (C-D) Postsynaptic light-evoked IPSCs 
recorded from LHb neurons at +10mV are attenuated by bath-application of 10 µM 
gabazine (n = 4 cells, t6 = 2.28, p = 0.06).  (E-G) Cell-attached recordings 
demonstrating a significant increase in the spontaneous firing rate of a subset LHb 
neurons in response to a 1s 20 Hz optical stimulation of VGlut2LH-LHb::ChR2 
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terminals in the LHb (n = 12 cells, F2,33 = 7.27, p = 0.002). (H,I) Cell-attached 
recordings demonstrating a decrease in the spontaneous firing rate from a LHb 
neurons in response to a 1s 20 Hz optical stimulation of VGlut2LH-LHb::ChR2 
terminals in the LHb.  (K) 1s 20 Hz optical stimulation of VGlut2LH-LHb::ChR2 
terminals in the LHb resulted in 70.6% of LHb neurons showing a net excitation, 
23.5% of LHb neurons showing less than a 20% change in firing, and 5.9% of LHb 
neurons showing a net inhibition (n = 17 neurons total).   
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Figure 4.4:  Optogenetic modulation of VGlut2LH-LHb circuit bidirectionally 
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modulates feeding and reward-related behaviors.  (A) Schematic for viral 
injection of AAV5-EF1a-DIO-NpHR3.0-eYFP into the LH of VGlut2-IRES-Cre mice 
(VGlut2LH-LHb::NpHR3.0). (B) Confocal images of coronal sections showing 
expression of NpHR3.0-eYFP in the LH and LHb of aVGlut2-IRES-Cre mouse.  
(C,D) Representative tracks from VGlut2LH-LHb::ChR2 (C) and VGlut2LH-LHb::NpHR3.0 
(D) during real time place preference task. (E) VGlut2LH-LHb::ChR2 spent less time on 
the side of the chamber paired with stimulation than VGlut2LH-LHb::Control mice (n = 
5 VGlut2LH-LHb::ChR2 mice and n = 7 VGlut2LH-LHb::Control mice, t10 = 5.9, p < 0.001).  
VGlut2LH-LHb::NpHR3.0 spent more time on the side of the chamber paired with 
stimulation than VGlut2LH-LHb::Control mice (n = 7 per group, t12 = 2.579, p = 0.017).  
(F) Example licks for ensure free-licking experiment for VGlut2LH-LHb::NpHR3.0 and 
VGlut2LH-LHb::Control mouse.  (G) VGlut2LH-LHb::NpHR3.0 licked more for a palatable 
liquid during a free-licking task than VGlut2LH-LHb::Control mice (n = 7 per group, t12 = 
2.374, p = 0.035). (H) VGlut2LH-LHb::NpHR3.0 had more licking bouts than VGlut2LH-
LHb::Control mice (n = 7 per group, t12 = 2.63, p = 0.02) (I) VGlut2LH-LHb::NpHR3.0 had 
a significantly lower Interbout Interval than VGlut2LH-LHb::Control mice (n = 7 per 
group, t12 = 2.56, p = 0.02). 
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CHAPTER 5: DISCUSSION 
Determining the causality between neural circuits and motivated behaviors, 
such as reward seeking and avoidance, are critical first steps in the development of 
novel treatments for neuropsychiatric diseases that occur when these circuits 
become perturbed.  Abnormalities in the function and connectivity of dopaminergic 
neurons are thought to underlie many neuropsychiatric diseases such as addiction, 
depression, anxiety, schizophrenia, ADHD, and autism (Chevallier et al., 2012; Goto 
and Grace, 2007; Jennings et al., 2013a; Lau et al., 2013; Nestler and Carlezon, 
2006; Viggiano et al., 2003; Wise and Koob, 2014; Zahm, 2010).  Thus, the main 
goal of this dissertation was to use innovative and novel techniques to determine 
how the functional connectivity between the VTA and LHb promote various aspects 
of motivated behaviors and to determine the functional and behavioral significance 
of this reciprocal connection.  
 I found that the LHb sends a robust glutamatergic projection to GABAergic 
neurons in the RMTg and VTA.  Previous studies have demonstrated that LHb 
neurons and midbrain dopaminergic neurons show opposite responses to 
motivationally relevant stimuli (Matsumoto and Hikosaka, 2007).  However, the 
mechanism by which LHb glutamatergic neurons inhibit VTA dopaminergic neurons 
was unclear.  Our data, along with other recently published studies, demonstrates 
that the LHb negatively modulates VTA dopaminergic neurons via the RMTg, a 
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recently characterized GABAergic midbrain structure (Barrot et al., 2012; Jhou et al., 
2009a, 2009b; Lammel et al., 2011; Matsui and Williams, 2011; Stamatakis and 
Stuber, 2012).  We next demonstrated that exposing an animal to a single aversive 
event increased excitatory synaptic strength in the LHb-to-RMTg circuit.  These data 
are important because it demonstrates how brief, but salient, negative experiences 
can have potent long lasting effects on this circuit.  I only recorded changes in 
synaptic strength one hour following the exposure to the aversive event, and thus, 
future studies could investigate how long this circuit remains potentiated.  I then 
demonstrated that optogenetic activation of this circuit resulted in passive, active, 
and conditioned behavioral avoidance.  Additionally, activation of the LHb-to-RMTg 
circuit promoted negative reinforcement, and disrupted ongoing positive 
reinforcement, suggesting that although activation of this circuit is aversive, it 
promotes motivated behavior to avoid a negative outcome.   
The majority of LHb afferents arise from forebrain areas, although the LHb 
also receives a substantial projection from the VTA (Gruber et al., 2007; Kim and 
Lee, 2012; Phillipson and Griffith, 1980; Poller et al., 2013; Shabel et al., 2012; 
Stamatakis et al., 2013; Warden et al., 2012).  In this dissertation, I investigated two 
of these afferents: the lateral hypothalamus and the VTA.  I found that a unique 
population of VTA neurons projects to the LHb and releases GABA, which in turn 
decreases LHb firing, and increases the spontaneous firing rate of VTA 
dopaminergic neurons.  Additionally, I found that activation of this circuit in vivo is 
rewarding and depends on LHb GABAergic signaling as well as downstream 
dopaminergic signaling.  Although I provided a thorough functional characterization 
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of the VTA-to-LHb pathway, it still remains unclear how, or when, LHb-projecting 
VTA dopaminergic neurons are activated.  LHb neurons exhibit a high basal firing 
rate both in slices (Fig. 3.4) and in vivo (Bromberg-Martin et al., 2010b; Meier and 
Herrling, 1993).  This high basal firing rate likely exerts a tonic inhibitory influence on 
dopaminergic neurons by activating RMTg GABAergic neurons that directly inhibit 
VTA dopaminergic neurons.  This circuitry may explain why inhibition of the LHb 
increases dopamine release in the forebrain (Lecourtier et al., 2008).   I hypothesize 
that the phasic dopamine release seen in the NAc in response to motivationally 
relevant stimuli, at least in part, could require activation of inhibitory afferents to the 
LHb, thus disinhibiting midbrain dopaminergic neurons.  This hypothesis is 
supported by the decreased firing rate of LHb neurons in response to cues that 
predict rewards (Matsumoto and Hikosaka, 2007).  Data presented here 
demonstrate that VTA neurons themselves send an inhibitory projection to the LHb, 
and thus are able to directly inhibit LHb neurons.  However, it remains unclear 
whether LHb-projecting neurons show changes in firing in response to motivationally 
relevant stimuli.  Future studies could use electrophysiology paired with optogenetics 
to identify and record from genetically-distinct projection-specific neurons in vivo 
(Jennings et al., 2013a) to investigate if, and if so when, LHb-projecting VTA 
dopaminergic neurons become activated in response to motivationally-relevant 
stimuli.  It would also be beneficial for future studies to compare these responses to 
NAc-projecting dopaminergic neurons in the same animals.  I hypothesize that LHb-
projecting VTA dopaminergic neurons will become activated in response to cues that 
predict rewards, which would provide a functional explanation for why activation of 
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this pathway in vivo is rewarding.  Further, I predict that NAc-projecting VTA 
dopaminergic neurons will also become activated by reward-predictive cues, but that 
the response latency between the two populations of neurons will be different. 
A significant outstanding question with regards to VTA circuitry is which VTA 
afferent is providing dopaminergic neurons with reward-related information?  It is 
clear that dopaminergic neurons show increased activation to reward and reward-
predictive cues, and this results in phasic dopamine release in the NAc, but it is 
unclear which VTA afferent is causing this increase in firing.  It is also likely that 
more than one VTA afferent are relaying various aspects of reward to the VTA.  For 
example, the PPTg preferentially responds to auditory stimuli, and thus may be 
providing dopaminergic neurons with information about reward-predictive auditory 
cues (Pan and Hyland, 2005).  On the other hand, the superior colliculus appears to 
relay information about visual cues to dopaminergic neurons (Coizet et al., 2003; 
Comoli et al., 2003; Dommett et al., 2005).  Future studies could inhibit select 
afferents while recording from VTA dopaminergic neurons during a reward-predictive 
cue to determine which afferent disrupts the cue-evoked spiking of dopaminergic 
neurons.  While it is still unclear which afferent is providing dopaminergic neurons 
with positive reward prediction error, recent evidence, including data generated in 
this dissertation, has suggested that the LHb is relaying negative reward prediction 
error to the VTA (Hong et al., 2011).  The LHb conveys negative reward information 
to the RMTg, which then robustly inhibits VTA dopaminergic neurons.  Here, I have 
shown that activation of LHb glutamatergic inputs to the RMTg promotes aversive 
behavioral phenotypes.  In addition, activation of LH glutamatergic afferents to the 
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LHb results in a similar behavioral phenotype.  Combined, these data suggest that 
the LH may be providing the LHb with negative reward prediction error, which in turn 
provides dopaminergic neurons with negative reward-related information via the 
RMTg.  Future studies could address this hypothesis by recording from 
dopaminergic neurons during negative reward prediction error tasks while 
simultaneously inhibiting either LH glutamatergic inputs to the LHb, LHb 
glutamatergic inputs to the RMTg, or RMTg GABAergic inputs to the VTA. 
I characterized a population of VTA dopaminergic neurons that project to the 
LHb and release GABA, but no detectable amounts of dopamine.  I targeted these 
neurons using a mouse line that expresses cre recombinase under a TH promoter.  
Indeed, I found that these neurons contain TH mRNA and TH protein in the soma, 
but little TH protein in the terminals.  These neurons also express mRNA for other 
markers for dopaminergic neurons, such as vesicular monoamine transporter, 
dopamine transporter, and dopamine D2 receptor, but at much lower levels than 
NAc-projecting dopaminergic neurons.   Thus, a significant outstanding question is 
whether or not these neurons should be characterized as dopaminergic or 
GABAergic.  One possibility is that the phenotype of these neurons is 
developmentally regulated.  It is possible that these neurons release dopamine 
during development, but then switch to releasing GABA once connectivity has been 
established.  A recent study has demonstrated strong labeling of tyrosine 
hydroxylase in dopaminergic afferents in the LHb from mouse embryos (Schmidt et 
al., 2014), and previous studies have shown that certain populations of neurons are 
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capable of switching their neuronal phenotype (Dulcis et al., 2013; Gómez-Lira et al., 
2005; Guemez-Gamboa et al., 2014; Telese et al., 2013).  
While the studies from this dissertation have provided pivotal insight into 
midbrain reward circuitry, it is important to discuss the limitations associated with 
these methods.  One of the main limitations of optogenetics is that the method 
typically either uniformly excites or inhibits a global population of genetically-distinct 
and/or projection-specific population of neurons.  While this technique provides a 
general understanding of the causality of a defined circuit, it may not represent the 
physiological state of the circuit.  For example, global activation of LHb glutamatergic 
inputs to the RMTg produced a robust aversive phenotype (Stamatakis and Stuber, 
2012).  However, it is possible that when an animal is exposed to an aversive 
stimulus, there may be subtle differences in either the timing or percentage of 
neuronal activation.  These subtleties are difficult to recapitulate with optogenetics 
but may have important differences on behavioral output.  
Another important caveat of optogenetic projection targeting techniques is 
that oftentimes afferent fibers are bundled together, and stimulating terminals in one 
region may also stimulate fibers of passage that are en route to a more distal target 
region.  For example, dopaminergic afferents from the VTA projecting to the mPFC 
pass through the NAc (Beckstead et al., 1979; Herbert et al., 1997), and stimulation 
of dopaminergic terminals in the NAc will also likely stimulate mPFC-projecting 
fibers.  Techniques that allow for retrograde delivery of viruses encoding opsins to 
specific presynaptic inputs may circumvent some of these limitations (Jennings and 
Stuber, 2014). 
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Another limitation of optogenetics is the possibility of back-propagating action 
potentials.  Optical stimulation of terminals in one region may lead to back-
propagating action potentials that activate the cell bodies, and can then activate 
afferents projecting to other regions.  However, this limitation can be addressed by 
injecting lidocaine to prevent back propagating action potentials at the level of the 
cell bodies of the population of neurons that was transduced (Stuber et al., 2011).  
Even if the targeted population of neurons do not collateralize, it is still important to 
determine if that population has local effects on network activity.  For example, 
although VTA dopaminergic neurons do not collateralize for the most part (Ford et 
al., 2006; Lammel et al., 2008; Stamatakis et al., 2013; Swanson, 1982), they do 
release dopamine locally (Adell and Artigas, 2004), which could be initiated by 
terminal optical stimulation.  
There are also important considerations that should be discussed when using 
cre-driver lines.  Data from this dissertation, as well as a number of recent studies, 
demonstrate that neurons can have phenotypes that are not consistent with a single 
neurotransmitter (Root et al., 2014; Shabel et al., 2014; Stuber et al., 2010; 
Tecuapetla et al., 2010; Tritsch et al., 2012).  Recent developments in cre-driver 
lines may begin to address this issue by utilizing tools to target neurons based on 
multiple genetic markers (Fenno et al., 2014).  In addition, the expression patterns of 
particular genes and proteins likely vary widely amongst a population of neurons 
targeted by cre-driver lines.  Differences in gene and protein expression likely have 
functional and physiological consequences, yet cre-mediated recombination does 
not reflect the differences in endogenous gene expression (Atasoy et al., 2008; 
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Sohal et al., 2009).  Finally, experiments using cre-driver lines often make the 
assumption that the neuronal population studied remains fixed throughout life.  
However, recent studies have demonstrated that the phenotype of certain 
populations of neurons are developmentally, environmentally, and epigenetically 
regulated (Andersson et al., 2006; Dulcis et al., 2013; Gómez-Lira et al., 2005; 
Guemez-Gamboa et al., 2014; Matsushita et al., 2002; Scott et al., 2013; Telese et 
al., 2013).   
Finally, as with all circuit-based experiments, it is important to put the 
particular circuit studied into a broader context of overall neural function and activity.  
While the techniques used in this dissertation have provided an elegant way to 
modulate a particular population of genetically-distinct, projection-specific neurons, 
isolation of a select circuit does not take into account simultaneous neural 
processing from other afferents or efferents, which likely act in concert to promote 
various behaviors.   
The inherent complexity and heterogeneity of VTA circuitry makes it a 
technically challenging, but elegant and prolific system to study. The resurgence of 
neurobiological techniques used to dissect neural circuits has allowed researchers to 
make great strides in understanding how precise neural circuit elements of reward 
circuitry contribute to motivated behavior (Jennings and Stuber, 2014).  Data 
generated from this dissertation has increased our understanding of the neural 
circuitry involved in processing aversive and rewarding stimuli, and may aid in the 
identification of novel targets for the treatment of addiction and other 
neuropsychiatric diseases. 
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